e10vk
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark One)
|
|
|
þ |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2010
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 0-17995
Zix Corporation
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Texas
|
|
75-2216818 |
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification Number) |
2711 N. Haskell Avenue, Suite 2200, LB 36, Dallas, Texas 75204-2960
(Address of Principal Executive Offices)
(214) 370-2000
(Registrants Telephone Number, Including Area Code)
Securities Registered Pursuant to Section 12(b) of the Act:
|
|
|
Title of each class of stock
|
|
Name of each exchange on which registered |
|
|
|
Common Stock
$0.01 Par Value
|
|
NASDAQ |
Indicate by check mark whether the Registrant is a well-known seasoned issuer, as defined in
Rule 405 of the Securities Act. Yes o No þ
Indicate by check mark whether the Registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the Act. Yes
o
No þ
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file such reports) and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the Registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such reports)
Yes o No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of
Registrants knowledge, in definitive proxy or information statements incorporated by reference in
Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
o Large accelerated filer
|
|
þ Accelerated filer
|
|
o Non-accelerated filer
(Do not check if a smaller reporting company)
|
|
o Smaller reporting company |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2
of the Exchange Act). Yes o No þ
As of March 7, 2011, there were 67,484,366 shares of Zix Corporation $0.01 par value common
stock outstanding. As of June 30, 2010, the aggregate market value of the shares of Zix Corporation
common stock held by non-affiliates was $143,477,786.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrants 2011 Proxy Statement are incorporated by reference into Part III
of this Form 10-K.
PART I
Item 1. Business
Zix Corporation (ZixCorp®, the Company, we, our, or us) is a leader in
providing email encryption services. ZixCorps Email Encryption Service enables the use of secure
email for sensitive information exchange primarily in the healthcare, financial services, insurance
and government sectors. More than 1,200 hospitals and over 1,500 financial institutions, including
some of the most influential companies and government organizations, use our Email Encryption
Service. Wellpoint, Humana, and the Securities and Exchange Commission (SEC) are among these
notable customers. Our Email Encryption Service is enhanced by ZixDirectory®, which
includes approximately 25 million members. ZixDirectory allows for emails to be sent seamlessly
whenever possible, across the largest email encryption community in the world.
Our Email Encryption Service is a comprehensive secure messaging service, which allows an
enterprise to use policy-driven rules to determine which emails should be sent securely to comply
with regulations or company defined policies. It is primarily offered as a Software-as-a-Service
(SaaS) solution, for which customers pay an annual service subscription fee. ZixCorps main
differentiation in the marketplace is our exceptional ease of use. The best example of this is our
ability to provide transparent delivery of secure, encrypted email. Most email encryption
solutions are focused on the sender. They typically introduce an added burden on receivers, often
requiring additional user authentication with creation of a new user identity and password. We
designed our solution to alleviate the receivers burden by enabling the delivery of encrypted
email automatically and transparently. ZixCorp enables transparent delivery by (1) ZixDirectory,
which is designed to share identities, (2) Zixs Best Method of Delivery, which is designed to
deliver email according to the senders encryption policy and (3) ZixGateway®, which is
an enterprise gateway that automatically decrypts the message. The result is secure encrypted
email exchange that is transparent for both sender and receiver.
Our business operations and service offerings are supported by the ZixData Center, a network
operations center dedicated to secure electronic transaction processing. The operations of the
ZixData Center are independently audited annually to maintain AICPA SysTrustSM
certification in the areas of security, confidentiality, integrity and availability. Auditors also
produce a SAS70 Type II report on the effectiveness of operational controls used over the audit
period. The center is staffed 24 hours a day with a proven 99.99% reliability rate.
Our company was incorporated in Texas in 1988. Originally named Amtech Corporation, we changed
our name to ZixIt® Corporation in 1999 when we entered the encrypted email market. In
2002, we became Zix Corporation. We entered the e-prescribing market in 2003, and on December 31,
2010, discontinued our operations in this business. Our executive offices are located at 2711 North
Haskell Avenue, Suite 2200, LB 36, Dallas, Texas 75204-2960, (214) 370-2000.
Email Encryption
Overview: Email is a mission-critical means of communication for enterprises. However,
if email leaves a secure network environment in clear text, it can be intercepted along the path
between a sender and a recipient, which permits theft, redirection, manipulation, or exposure to
unauthorized parties. Failure to control and manage such risks can result in enforcement penalties
for noncompliance under numerous different regulations, in addition to damaged reputation,
competitive disadvantage, a loss of intellectual property or other corporate assets, exposure to
negligence or liability claims, and diversion of resources to repair such damage. For example,
healthcare organizations are subject to the Health Information Portability Accountability Act
(HIPAA) as recently revised by the Health Information Technology for Economic and Clinical Health
Act of 2009 (HITECH ACT). Financial institutions are subject to data privacy laws included in
the Gramm-Leach-Bliley Act (GLBA). In addition, individual states such as Massachusetts and
Nevada have recently introduced state laws regulating email encryption.
Corporations require email protection that can be used on an enterprise-wide basis, is
cost-effective, quickly deployed, regularly updated to guard against obsolescence and
ineffectiveness, and is easy to use. To satisfy these needs, our Email Encryption Service provides
a comprehensive solution that analyzes and encrypts email communications.
3
Our Email Encryption Service provides a user the ability to deliver encrypted email to any
email user at any email address by using the ZixCorp Best Method of Delivery protocol that
automatically determines the most direct and appropriate means of delivery, based on the senders
and recipients communications environment and preferences. The service supports a number of
encrypted email delivery mechanisms, including S/MIME, TLS, OpenPGP, push delivery and secure
portal pull delivery. These last two mechanisms enable users to send messages instantly and
securely to anyone with an email address, including those who do not have an encryption tool. Our
Best Method of Delivery makes the technology simple for end users and provides flexibility and ease
of implementation for information technology professionals. We believe the ability to send messages
through different modes of delivery makes our Email Encryption Service superior to competitive
offerings.
The deployment of our Email Encryption Service at the periphery of the customers network
means our Email Encryption Service encrypts email for an enterprises customers and business
partners without the need to create, deploy or manage end user encryption keys or deploy desktop
software. Our technology solutions are user friendly, easy to deploy, and can be made operational
quickly.
Our service has an integrated policy management capability. This policy engine can inspect the
contents of emails and apply policies that match specific industry criteria such as HIPAA and GLBA.
Customers can also build their own specific policies. This policy driven email for regulatory
compliance means customers can reduce the training required of their staff and significantly reduce
the risk of inadvertently sending sensitive content by regulating the method of delivery through
preset policies.
Our Email Encryption Service employs a centralized directory of users called the ZixDirectory,
which we consider a key differentiator of our offering. The ZixDirectory operates as a global
community for email encryption, and today contains approximately 25 million members. The
ZixDirectory has recently grown at a rate of approximately 100,000 new members per week. Access to
these email addresses and encryption codes in the ZixDirectory greatly improves ease of use for
both senders and receivers of secure email, while affording them the option of strong encryption
methods, extended feature sets and the flexibility of a variety of fully integrated and fully
interoperable solutions.
Today in the healthcare industry, our Email Encryption Service is used by over thirty Blue
Cross Blue Shield organizations and over 1,200 hospitals. In the financial services sector, we
serve over 1,500 banks, credit unions and farm credit associations, as well as all of the Federal
Financial Institutions Examination Council (FFIEC) regulators. We also provide service to more
than twenty-five state governments covering various agencies in those states.
Competition: The most significant differentiator for ZixCorp as compared with competition is
ease of use. The best example of our unequalled ease of use is transparent delivery of encrypted
email messages. We are able to deliver transparent email encryption as a result of our SaaS
architecture, the ZixDirectory, the Best Method of Delivery and the ZixGateway. The most critical
and highly differentiated component of our solution is the ZixDirectory which provides the ability
to share user identities for encryption, which in turn provides interoperability between users in a
community of interest within healthcare, finance or government.
In addition, our service differs from the products and services of most of our competitors
because we offer a SaaS architecture, while most of our competitors offer primarily a product-based
approach that the customer builds and runs themselves. Some of our competitors have substantial
information technology security and email protection products, however, our competitors customers
tend to build and operate their own systems, and the directory of user identities each competitor
creates is not shared. This practice is less desirable as different companies encrypted email
systems are not interoperable.
Our capability to offer interoperability is particularly important when it is necessary to
communicate with external networks, as is the case with the healthcare and financial services
markets. Our customers become part of the ZixDirectory, a global white pages that enables
transparent secure communications with other ZixGateway customers using our centralized key
management system and overall unique approach to implementing secure e-messaging technology. We
enable secure communications with other users via our push and secure portal delivery mechanisms.
However, we believe our unique transparent delivery is the more preferred delivery model.
4
Our Email Encryption Service focuses on the secure (encryption) delivery portion of the secure
email market, a sub-segment of the e-messaging market. We view our primary competitors as IronPort
Systems, Inc. (acquired by Cisco Systems Inc.), Proofpoint Inc., and McAfee, Inc. Technically,
while these companies offer send-to-anyone encrypted email, we believe they are unable to offer
the benefits that come from access to the ZixDirectory and from using our Best Method of Delivery
protocol. Nevertheless, some of these competitors are large enterprises with substantial financial
and technical resources that exceed those we possess. There are other competitors but we do not
view them as particularly significant.
e-Prescribing
Overview: On December 8, 2009, the Company filed a Current Report on Form 8-K
disclosing the decision by the Companys Board of Directors to exit the e-Prescribing business by
winding down its operations while servicing existing contractual obligations to current customers.
The Company targeted December 31, 2010, as the official termination date for this business, due in
large measure to the expiration of ongoing contractual commitments by that date. On December 31,
2010, the Company successfully completed its wind down plan and exited the e-Prescribing business.
As a result, this business has now been reclassified as a discontinued operation in the Companys
Statements of Operations on a retrospective basis. There were no significant assets or liabilities
related to the discontinued operations at December 31, 2010.
Regulatory Drivers
We have been successful in securing additional market penetration for our Email Encryption
Service in our target vertical markets of healthcare, finance services and government. There was a
significant increase in demand in the healthcare sector leading up to the April 2005 HIPAA Security
Rule deadline and sales in this sector have remained generally strong since that time. The HITECH
Act within the American Recovery and Reinvestment Act of 2009, also known as the stimulus package,
contains an expansion of the HIPAA laws that went into effect following the February 17, 2009,
passage of the law. Key elements of the HITECH Act relating to HIPAA include increased penalties
for violations, stricter and more onerous breach notification requirements, an expanded reach of
the law to include previously uncovered business associates, and the ability for states to pursue
HIPAA violations in addition to the U.S Department of Health and Human Services (HHS). The
Company believes these changes will continue to increase demand for email encryption by broadening
the potential market and providing further incentive for potential customers to adopt email
encryption technology.
Additional federal regulations, such as GLBA, and state regulations across the country have
enhanced security awareness in vertical markets outside of healthcare, and have prompted affected
organizations to consider adopting systems that ensure data security and privacy.
Recently, state governments have begun to focus increasingly on encryption. The first of the
email encryption state laws was passed by Nevada on October 1, 2008. On March 1, 2010, new
regulations in the state of Massachusetts became effective (201 CMR 17.00). The Massachusetts
regulations bear the most comprehensive encryption requirements imposed on businesses by any state
and, because they cover any business with a customer or business dealing in the state of
Massachusetts, they reach far beyond Massachusetts state borders.
Even where there are no specific regulations, corporations may demand email protection to
adhere to evolving industry best practices for protecting sensitive information. In 2003 we
responded to these trends by expanding our focus beyond healthcare into other vertical markets
including financial services, insurance and government. As part of the strategy to penetrate the
financial services sector, we targeted the relevant regulators who themselves were placing an
increased emphasis on the secure transmission of sensitive
information. All of
the federal regulators who comprise the FFIEC are our customers and our service is a recommended
solution of the Conference of State Bank Supervisors, whose members regulate the more than 6,000
state-chartered banks in the U.S. State banking regulators in more than twenty states.
5
Sales and Marketing
We sell our Email Encryption Service through a direct sales force that focuses on larger
businesses and a telesales force that focuses on small to medium-sized accounts. We also use a
network of resellers and other distribution partners, including other service providers seeking an
encryption offering in an original equipment manufacturing (OEM)-like relationship. New Email
Encryption first year orders derived from our valued added resellers, OEM and third party
distribution channels for 2010 were 53% of the total new first year orders compared to 33% in 2009.
Google, Inc. continues to be our largest third party reseller representing approximately 10% of
new first year orders in 2010. We now have over 100 managed security service providers and value
added resellers across the U.S.
Employees
We had 123 employees as of December 31, 2010. The majority of our employees are located in
Dallas, Texas; Burlington, Massachusetts; and Ottawa, Ontario, Canada.
Research and Development Patents and Trademarks
We incurred research and development expenses from continuing operations of $5,089,000,
$3,619,000, and $2,677,000 for the twelve-month periods ended December 31, 2010, 2009 and 2008,
respectively.
Over the course of 2010 we continued to make investments to strengthen our Email Encryption
services by completing development of and releasing a number of service upgrades. We delivered
ZixGateway 4.0, an upgrade to our policy-based appliance that provides support for virtualization,
multiple languages and DomainKeys Identified Mail (DKIM). We also completed and released ZixPort®
3.7, an upgrade to our portal-based service which provides language localization, increased large
file support and support for the iPhone®. We updated our software platform for the
desktop client portfolio to align with recent computing technology evolution and advancements and
delivered new versions which are aligned to Microsoft® Office 2010. In addition, we
designed a set of tools to improve the automation level and efficiency of the customer provisioning
process for our resellers and distributors. This will allow our third-party channels to deploy our
service more quickly.
We have patents that protect certain elements of our core technology underlying the Email
Encryption business. We have not realized any revenues from licensing any of our patents to third
parties, and did not receive any new U.S. patents in 2010.
The following are registered trademarks of ours and certain of our subsidiaries: ZixCorp,
ZixGateway, ZixDirectory, ZixIt, ZixPort, and PocketScript.
Compliance with Environmental Regulations
We have not incurred, and do not expect to incur, any material expenditures or obligations
related to environmental compliance issues.
Governmental Contracts
We have contracts with many local, state and federal agencies and regulators, which contribute
approximately five percent of our annual revenue.
Significant Customers
In each of 2010, 2009 and in 2008 no single customer accounted for 10% or more of our total
revenues.
Backlog
Our end user order backlog is comprised of contractual commitments that we expect to recognize
as revenue in the future. Backlog consists of the following at December 31, 2010 and 2009:
6
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010 |
|
|
December 31, 2009 |
|
Email Encryption |
|
$ |
49,911,000 |
|
|
$ |
42,901,000 |
|
e-Prescribing |
|
|
|
|
|
|
1,399,000 |
|
|
|
|
|
|
|
|
Total backlog |
|
$ |
49,911,000 |
|
|
$ |
44,300,000 |
|
|
|
|
|
|
|
|
As of December 31, 2010, our backlog is comprised of the following elements: $16,770,000 of
deferred revenue that has been billed and paid, $5,168,000 billed but unpaid net, and
approximately $27,973,000 of unbilled contracts.
The backlog is recognized into revenue as the services are performed. Approximately 55% of our
total backlog as of December 31, 2010 is expected to be recognized as revenue during 2011. The
timing of revenue recognition is affected by both the length of time required to deploy a service
and the length of the service contract.
Seasonality
Our business is not materially impacted by seasonality.
Geographic Information
Our operations are primarily based in the U.S., with approximately 9% of our employees located
in Canada. Except for a United Kingdom based data center, we do not operate in, or have
dependencies on, any other foreign countries. Our revenues and orders to-date are almost entirely
sourced in the U.S. and all significant corporate assets at December 31, 2010, were located in the
U.S.
Available Information
Our Internet address is www.zixcorp.com. Our Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant
to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act),
are available on our website, without charge, as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the SEC. The information found on our
website shall not be considered to be part of this or any other report filed with or furnished to
the SEC.
In addition to our website, you may read and copy any materials we file with the SEC at the
SECs Public Reference Room at 450 Fifth Street, N.W., Washington, D.C. 20549. You may obtain
information on the operation of the SECs Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC maintains a website that contains reports, proxy and other information
statements, and other information regarding issuers, including us, that file electronically with
the SEC. The address of the website is www.sec.gov.
Item 1A. Risk Factors
The risks and uncertainties described below could materially and adversely affect our
business, financial condition and financial results and reduce the value of an investment in our
securities. This report also contains forward-looking statements and the following risks could
cause our actual results to differ materially from those anticipated in such forward-looking
statements.
Our Email Encryption business depends upon customers using email to exchange confidential
information, and a significant shift of those messages to other communication channels could impair
our growth prospects and negatively affect our business, financial condition and financial results.
Our Email Encryption customers deploy and use our products and services to easily, securely
and confidentially send and receive encrypted email messages. Our Email Encryption business and
revenue substantially depend on our current and potential customers using email to exchange
sensitive information electronically. New technologies or products, or new business models that
could support secure communications, could be disruptive to our business. If prospective or current
customers were to send and receive sensitive information using technology or communication
7
channels other than ours, our growth prospects and our business, financial condition and
financial results could be materially adversely affected.
Public key cryptography technology used in our businesses is subject to technology integrity risks
that could reduce demand for our products and services and could negatively affect our business,
financial condition and financial results.
Our Email Encryption business employs public key cryptography technology and other encryption
technologies to encrypt and decrypt messages. The security afforded by encryption depends on the
integrity of the private key, which is predicated on the assumption that it is very difficult to
mathematically derive the private key from the related public key. Successful decryption of
encrypted information, or public reports of successful decryption, whether or not true, could
reduce demand for our products and services. If new methods or technologies make it easier to
derive the private key from the related public key, the security of encryption services using
public key cryptography technology could be impaired and our products and services could become
unmarketable. That could require us to make significant changes to our services, which could
increase our costs, damage our reputation, or otherwise harm our business. Any of these events
could reduce our revenues and materially adversely affect our business, financial condition and
financial results.
The growth of our business may require significant investment in systems and infrastructure with no
guarantee of revenue, which could impair our profitability and negatively affect our business,
financial condition and financial results.
As our operations grow in size and scope, we may need to improve and upgrade our systems and
infrastructure to offer an increasing number of customers enhanced products, services, features and
functionality, while maintaining the reliability and integrity of our systems and infrastructure
and pursuing reduced costs per transaction. Expanding our systems and infrastructure may require us
to commit substantial financial, operational and technical resources, with no assurance that the
volume of our business will increase, which could reduce our net income, deplete our cash, and
materially adversely affect our business, financial condition and financial results.
We face strong competition, which could negatively affect our business, financial condition and
financial results.
The markets in which we compete are characterized by rapid change and converging technologies
and are very competitive. With rising demand for private and secure email communications, there is
strong competition for the email encryption products and services. Our Email Encryption business
competes with products and services offered by companies such as Axway, Ironport (acquired by Cisco
Systems Inc.), Echoworx, McAfee, Inc., PGP Corporation, Proofpoint, Trend Micro and Voltage
Security. Strong competition requires us to develop new technology solutions and service offerings
to expand the functionality and value that we offer to our customers. Some of our competitors offer
email encryption services together with products and services that we do not offer, which could
make our offering less attractive by comparison. As a result of the bundling of products by these
competitors, it can be difficult for our customers to compare the cost of our products with
competing products. In some instances, competing products may seem to be offered by our
competitors at little to no additional cost to the customer. In addition, our competitors may
develop technology solutions and service offerings that are perceived by customers as equivalent
to, or having advantages over, our products and services. Competitors could capture a significant
share in our markets, causing our sales and revenue to decline or grow more slowly. Barriers to
entry are relatively low, and new ventures to create products that compete with our products are
regularly formed. Competitive pressures could lead to price discounting or to increases in
expenses such as advertising and marketing costs. Increased competition could also decrease demand
for our products and services. Competition could reduce our revenues and net income and materially
adversely affect our business, financial condition and financial results.
8
Some competitors have advantages that may allow them to compete more effectively than us, which
could negatively affect our business, financial condition and financial results.
Some of our competitors have longer operating histories, more extensive operations, greater
name recognition, larger technical staffs, bigger product development and acquisition budgets,
established relationships with more distributors and hardware vendors, and greater financial and
marketing resources than we do. These resource advantages might enable them (independently or
through alliances) to develop and expand functionality of products and services faster than we can,
to spend more money to market and distribute products and services than we can, or to offer their
products and services at prices lower than ours. These advantages could reduce our revenues and net
income and materially adversely affect our business, financial condition and financial results.
We plan to increasingly rely on third party distributors to help us market our Email Encryption
products and services, and our failure to succeed in those relationships could negatively affect
our business, financial condition and financial results.
We plan to increase the distribution of our Email Encryption products and services by entering
into alliances with third parties who can offer our products and services along with their own
products and services. Increased reliance on third parties to market and distribute our products
and services exposes us to a variety of risks. For example, we have limited control over the timing
of the delivery of our products to customers by third party distributors, which could increase the
length of our sales cycle, cause our revenue to fluctuate unpredictably and make it difficult to
accurately forecast our revenue. We may not succeed in developing or maintaining marketing
alliances. Companies with which we have marketing alliances may in the future discontinue their
relationships with us, form marketing alliances with our competitors, or develop and market their
own products and services that compete with ours. If a significant distributor were to discontinue
its relationship with us, we could experience an interruption in the distribution of our products
and services and our revenues could decline. Our failure to develop, maintain and expand strategic
distribution relationships could reduce our revenues and net income and materially adversely affect
our business, financial condition and financial results.
Our business depends on market acceptance of our Email Encryption service, and our failure to
achieve market penetration could negatively affect our business, financial condition and financial
results.
Our revenue and financial results are dependent on our Email Encryption business. In order to
continue to operate profitably, we must achieve broad market acceptance of our Email Encryption
service at a price that provides an acceptable rate of return relative to our costs. We have been
successful in selling our products and services to various high-profile customers, particularly in
the healthcare, financial services and government segments of our market. The acceptance and use of
our Email Encryption products and services by those significant customers facilitates our sales to
potential customers, and an expanding base of users in the Zix Directory aids in our market
penetration and expansion. We must continue to respond to evolving business models for technology
offerings in order to achieve market acceptance. The loss of an influential customer could impair
our ability to expand the market penetration of our products and services, or cause us to reduce
prices, which could reduce our revenues and net income and materially adversely affect our
business, financial condition and financial results.
Unfavorable economic and political environments could negatively affect our business, financial
condition and financial results.
Challenging economic conditions worldwide have from time to time contributed, and may continue
to contribute, to slowdows in technology and networking industries at large, as well as in the
specific markets in which we operate. If economic growth in those markets is slow, or credit is
unavailable at a reasonable cost, current and potential customers may delay or reduce technology
purchases, including the deployment or expansion of our Email Encryption products and services.
This could result in reduced sales of our products and services, longer sales cycles, slower
adoption of new technologies and increased price competition. In addition, adverse economic
conditions could negatively affect the cash flow of our customers and distributors, which might
result in failures or delays in payments to us. This could increase our credit risk exposure and
delay our recognition of revenue. Specific economic trends, such as declines in the demand for PCs,
services and other computing devices, or softness in corporate information technology spending,
could have a more direct impact on our business. If these conditions
9
remain uncertain or persist, spread or deteriorate further, our business, financial condition
and financial results could be materially adversely affected.
Our failure to keep pace with rapid technology changes could have a negative impact on our
business, financial condition and financial results.
The markets for our products and services are characterized by rapid technological
developments and frequent changes in customer requirements. We must continually improve the
performance, features and reliability of our products and services, particularly in response to
competitive offerings, to keep pace with these developments. We must ensure that our products and
services address evolving operating environments, industry trends, certifications and standards.
For example we must expand our offerings for virtual computer environments and mobile environments
to support a broader range of mobile devices. We also must develop products that are compatible
with new operating systems while remaining compatible with existing, popular operating systems. Our
business could be harmed by our competitors announcing or introducing new products and services
that could be perceived by customers as superior to ours. We spend considerable resources on
technology research and development, but our research and development resources are more limited
than many of our competitors. Our business substantially depends on our ability to keep pace with
rapid technological and market changes and we may be unable to introduce new or enhanced products
into the market on a timely basis, or at all. Our enhancements to existing products and services,
or our potential new products and services, may not receive customer acceptance. Our failure to
introduce new or enhanced products on a timely basis, to keep pace with rapid industry,
technological or market changes or to gain customer acceptance for our products and services could
have a material adverse effect on our business, financial condition and financial results.
If our products do not work properly, our business, financial condition and financial results could
be negatively affected and we could experience negative publicity, declining sales and legal
liability.
We produce complex products that incorporate leading-edge technology, including both hardware
and software, that must operate in a wide variety of technology environments. Software may contain
defects or bugs that can interfere with expected operations. There can be no assurance that our
testing programs will be adequate to detect all defects prior to the product being introduced,
which might decrease customer satisfaction with our products and services. The product
reengineering cost to remedy a product defect could be material to our operating results. Our
inability to cure a product defect could result in the temporary or permanent withdrawal of a
product or service, negative publicity, damage to our reputation, failure to achieve market
acceptance, lost revenue and increased expense, any of which could have a material adverse effect
on our business, financial condition and financial results.
The infrastructure supporting our Email Encryption business may suffer capacity constraints and
business interruptions that could cause us to lose customers, increase our operating costs and
could negatively affect our business, financial condition and financial results.
Our business depends on our providing our customers reliable, real-time access to our data
centers and networks. Customers will not tolerate a service hampered by slow delivery times,
unreliable service levels, service outages, or insufficient capacity. System capacity limits or
constraints arising from unexpected increases in our volume of business could cause interruptions,
outages or delays in our services, or deterioration in their performance, or could impair our
ability to process transactions. We may not be able to accurately project the rate of increase in
usage of our network or to timely increase capacity to accommodate increased traffic on our
network. System delays or interruptions may prevent us from efficiently providing services to our
customers or other third parties, which could result in our losing customers and revenues, or
incurring liabilities that could have a material adverse effect on our business, financial
condition and financial results.
10
Our Email Encryption business depends substantially on our data center facilities, and their
unreliability or unavailability for a significant period could cause us to lose customers and could
negatively affect our business, financial condition and financial results.
Much of the computer and communications hardware upon which our businesses depend is located
in our data center facilities in Dallas and Austin, Texas and in the United Kingdom. Our data
centers might be damaged or interrupted by fire, flood, power loss, telecommunications failure,
break-ins, earthquakes, terrorist attacks, hostilities or war or other events. Computer viruses,
denial of service attacks, physical or electronic break-ins and similar disruptions affecting the
internet or our systems might cause service interruptions, delays and loss of critical data, and
could prevent us from providing our services. Problems affecting our systems might be expensive to
remedy and could significantly diminish our reputation and prevent us from providing services. An
incident that interrupts our data center operations or our networks could result in loss of
revenues, failure to achieve market acceptance, diversion of resources, injury to our reputation,
liability and increased costs. We do not carry sufficient insurance to compensate us for all
reasonably conceivable losses that may occur as a result of any of these events. The occurrence of
any of these events could materially adversely affect our business, financial condition and
financial results.
Outages or problems with systems and infrastructure supplied by third parties could negatively
affect our business, financial condition and financial results.
Our businesses rely on third-party suppliers of the global telecommunications infrastructure.
We use various communications service suppliers and the global internet to provide network access
between our data centers, our customers and end-users of our services. If those suppliers do not
enable us to provide our customers with reliable, real-time access to our systems, we may be unable
to gain or retain customers. These suppliers periodically experience outages or other operational
problems. Any of these outages or problems could materially adversely affect our business,
financial condition and financial results.
Problems with enforcing our intellectual property rights or using third party intellectual property
could negatively affect our business, financial condition and financial results. Our proprietary
rights may be difficult to enforce and may offer limited protection of our intellectual property
rights against potential infringers.
We rely on a combination of contractual rights, trademarks, trade secrets, patents and
copyrights to establish and protect proprietary rights in our products and services. These
intellectual property rights or other proprietary rights might be challenged, invalidated or
circumvented. The steps we have taken to protect our proprietary information may not prevent its
misuse, theft or misappropriation. Competitors may independently develop technologies or products
that are substantially equivalent or superior to our products or that inappropriately incorporate
our proprietary technology into their products. Competitors may hire our former employees who may
misappropriate our proprietary technology. Some jurisdictions may not provide adequate legal
protection of our intellectual property rights.
We may have to defend our rights in intellectual property that we use in our services, and we could
be found to infringe the intellectual property rights of others, which could be disruptive and
expensive to our business.
We may have to defend against claims that we or our customers are infringing the rights of
third parties in patents, copyrights, trademarks and other intellectual property. If we acquire
technology to include in our products from third parties, our exposure to infringement actions may
increase because we must rely upon these third parties to verify the origin and ownership of such
technology. Intellectual property litigation and controversies are disruptive and expensive. Even
unmeritorious claims brought against our customers may harm our reputation and customer
relationships, and may have to be settled for significant amounts. Infringement claims could
require us to develop non-infringing services or enter into expensive royalty or licensing
arrangements. Our business, financial condition and financial results could be materially adversely
affected if we are not able to develop non-infringing technology or license technology on
commercially reasonable terms.
11
We may face risks from using open source software that could negatively affect our business,
financial condition and financial results.
Like many other software companies, we may use open source software in order to add
functionality to our products quickly and inexpensively. Open source software license terms could
adversely affect our intellectual property rights in our products that include open source
software. We could lose the right to use the open source code if we fail to comply with the license
obligations. Using open source code could also cause us to inadvertently infringe third-party
intellectual property rights. We have processes and controls in place that are designed to address
these risks and concerns, but we cannot be sure that all open source is submitted for approval
prior to use in our products.
We may fail to recruit and retain key personnel, which could impair our ability to meet key
objectives.
Our success depends on our ability to attract and retain highly-skilled technical, managerial,
sales, and marketing personnel. Changes in key personnel may be disruptive to our business. It
could be difficult, time consuming and expensive to replace key personnel. Integrating new key
personnel may be difficult and costly. Volatility, lack of positive performance in our stock price
or changes to our overall compensation program including our stock incentive program may adversely
affect our ability to retain key employees, virtually all of whom are compensated, in part, based
on the performance of our stock price. The loss of services of any of our key personnel, the
inability to retain and attract qualified personnel in the future or delays in hiring required
personnel could make it difficult to meet key objectives. Any of these impairments related to
our key personnel could negatively affect our business, financial condition and financial results.
Our usage of personal information, and inadvertent exposure of confidential information, could
cause us to violate data privacy laws or lose customers and could negatively affect our business,
financial condition and financial results.
In our Email Encryption business, we collect, process, store, use and transmit large amounts
of personally identifiable information about individuals, such as personal healthcare or financial
information. Our handling of these types of data is increasingly subject to regulation around the
world. These regulations may result in conflicting requirements. Our business could be materially
adversely affected if legal restrictions on the use of personally identifiable information are
expanded or are interpreted in ways that conflict with our business practices or increase our
costs. Unauthorized disclosure of personal information (including through intrusion by a hacker) or
other failure by us to comply with data privacy requirements could subject us to significant
penalties, remediation and other expenses, and damage to our reputation, any of which could have a
material adverse effect on our business, financial condition and financial results.
Governmental restrictions on the sale of our products and services in non-U.S. markets could
negatively affect our business, financial condition and financial results.
Exports of software solutions and services using encryption technology, such as our Email
Encryption Service, are generally restricted by the U.S. government. Although we have obtained U.S.
government approval to export our Email Encryption service to almost all countries, the list of
countries to which we cannot export our products and services could be expanded in the future. In
addition, some countries impose restrictions on the use of encryption solutions and services such
as ours. The cost of compliance with U.S. and other export laws, or our failure to obtain
governmental approvals to offer our products and services in non-U.S. markets, could affect our
ability to sell our products and services and could impair our international expansion. We face a
variety of other legal and compliance risks. If we or our distributors fail to comply with
applicable law and regulations, we may become subject to penalties, fines or restrictions that
could materially adversely affect our business, financial condition and financial results.
12
Our financial performance could be erratic and asset impairments could negatively affect our
financial condition and financial results.
Although we generate adequate cash flow from operations and we expect to be profitable, we may
not continue to produce sufficient cash flow or show a profit. Our balance sheets reflect goodwill
relating to our Email Encryption business, as well as other assets. We periodically evaluate the
carrying value of our goodwill and other assets to determine if their values have been impaired,
which could require us to recognize a non-cash charge to earnings. Any of these circumstances could
materially adversely affect our business, financial condition and financial results.
The market price of our securities could be volatile and our securities may decline in value.
The market price of our common stock has fluctuated significantly in the past and is likely to
fluctuate in the future. In addition to stock price volatility related to our business performance,
our stock price may fluctuate due to events affecting our industry or our competitors, as well as
general economic and political conditions or otherwise. In addition, the stock market has
experienced extreme price and volume fluctuations that have affected the market price of many
technology companies in general, and such fluctuations were often unrelated to the operating
performance of these companies. These fluctuations have and will continue to affect smaller
capitalized technology companies like us. Any of these circumstances could cause our securities to
decline in value.
Exercises of options and warrants for our common stock would dilute the ownership interests of
existing shareholders and could negatively affect the value of our securities.
We have a significant number of outstanding warrants and options, including options held by
our employees. The exercise of warrants or options, and the resulting issuance of additional shares
of our common stock, would substantially dilute the ownership interests and voting rights of our
current shareholders. Issuance or sales of those additional shares could cause our securities to
decline in value.
Our issuances of additional debt or equity securities could dilute the ownership interests of
existing shareholders and could negatively affect the value of our securities.
We may issue additional debt or equity securities, including convertible debt, common and
convertible preferred stock, and warrants to acquire common or preferred stock. Those securities
could be issued in public or private transactions, at or below the then-prevailing market price of
our securities. In addition, we may grant our employees shares of our common stock and options to
purchase those shares. Our issuance of additional securities could substantially dilute the
ownership interests and voting rights of our current shareholders. Issuance or sales of those
additional shares could cause our securities to decline in value.
NOTE ON FORWARD-LOOKING STATEMENTS AND RISK FACTORS
This document contains forward-looking statements (including the discussion appearing under
the caption Liquidity Summary in Item 7. Managements Discussion and Analysis of Financial
Condition and Results of Operations, within the meaning of Section 27A of the Securities Act of
1933, as amended (the Act) and Section 21E of the Exchange Act. All statements other than
statements of historical fact are forward-looking statements for purposes of federal and state
securities laws, including: any projections of future business, market share, earnings, revenues,
cash receipts, or other financial items; any statements of the plans, strategies, and objectives of
management for future operations; any statements concerning proposed new products, services, or
developments; any statements regarding future economic conditions or performance; any statements of
belief; and any statements of assumptions underlying any of the foregoing. Forward-looking
statements may include the words may, will, predict, project, forecast, plan, should,
could, goal, estimate, intend, continue, believe, expect, outlook, anticipate,
hope, and other similar expressions. Any forward-looking statements involve risks and
uncertainties that could cause actual events or results to differ materially from the events or
results described in the forward-looking statements, including, but not limited to, the risks and
uncertainties described in the Risk Factors section above.
13
Although we believe that expectations reflected in any of our forward-looking statements are
reasonable, actual results could differ materially from those projected or assumed in any of our
forward-looking statements. Our future financial condition and results of operations, as well as
any forward-looking statements, are subject to change and to inherent risks and uncertainties, such
as those disclosed in this document. We do not intend, and undertake no obligation, to update any
forward-looking statement.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
During 2010 we leased properties that are considered significant to the operations of the
business in the following locations: Burlington, Massachusetts; Ottawa, Ontario, Canada; the United
Kingdom; and Dallas and Austin, Texas. The Burlington location is used for Email Encryption sales
and marketing activities. The Ottawa office is used for client services and sales support
activities. The United Kingdom facility provides data center support for our European customers.
The Dallas office is our headquarters, which includes research & development, marketing, sales and
all general administrative services, and the ZixData Center. Our Austin location is used primarily
for fail-over and business continuity services and is used to some extent to support normal ongoing
operations. Our facilities are suitable for our current needs and are considered adequate to
support expected near term growth.
Item 3. Legal Proceedings
We are subject to legal proceedings, claims, and litigation arising in the ordinary course of
our business. While the outcome of these matters is currently not determinable, we do not expect
that the ultimate costs to resolve these matters will have a material adverse effect on our
consolidated financial statements.
Item 4. (Removed and Reserved)
14
PART II
Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock trades on The Nasdaq Stock Market under the symbol ZIXI. The table below
shows the high and low sales prices by quarter for fiscal 2010 and 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
2009 |
|
Quarter Ended |
|
High |
|
|
Low |
|
|
High |
|
|
Low |
|
March 31 |
|
$ |
2.51 |
|
|
$ |
1.69 |
|
|
$ |
1.73 |
|
|
$ |
0.88 |
|
June 30 |
|
$ |
2.70 |
|
|
$ |
2.09 |
|
|
$ |
1.94 |
|
|
$ |
0.95 |
|
September 30 |
|
$ |
2.94 |
|
|
$ |
2.10 |
|
|
$ |
2.54 |
|
|
$ |
1.49 |
|
December 31 |
|
$ |
4.55 |
|
|
$ |
2.70 |
|
|
$ |
2.30 |
|
|
$ |
1.53 |
|
At March 7, 2011, there were 67,484,366 shares of common stock outstanding held by 497
stockholders of record. On that date, the last reported sales price of the common stock was $3.59.
We have not paid any cash dividends on our common stock and do not anticipate doing so in the
foreseeable future.
For information regarding stock-based compensation awards outstanding and available for future
grants, see Item 12. Security Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters.
During 2010, we did not engage in any share repurchase program of our common stock.
Performance Graph
The following graph compares the cumulative total return of an investment in our common stock
over the five-year period ended December 31, 2010, as compared with the cumulative total return of an
investment in (i) the Center for Research in Securities Prices (CRSP) Total Return Index for
Nasdaq Stock Market (U.S. companies) and (ii) the CRSP Total Return Index for Nasdaq Computer and
Data Processing Stocks. The comparison assumes $100 was invested on December 31, 2005, in our
common stock and in each of the two indices and assumes reinvestment of dividends, if any. The
stock price performance on the following graph is not necessarily indicative of future stock
performance. A listing of the companies comprising each of the CRSP- NASDAQ indices used in the
following graph is available, without charge, upon written request.
15
Item 6. Selected Financial Data
The following selected financial data should be read in conjunction with Item 7. Managements
Discussion and Analysis of Financial Condition and Results of Operations, the consolidated
financial statements and notes thereto. No cash dividends were declared in any of the five years
shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
2007 |
|
|
2006 |
|
|
|
(In thousands, except per share data) |
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
33,066 |
|
|
$ |
26,407 |
|
|
$ |
22,604 |
|
|
$ |
17,982 |
|
|
$ |
14,094 |
|
Cost of revenues |
|
|
6,468 |
|
|
|
4,576 |
|
|
|
4,105 |
|
|
|
4,361 |
|
|
|
5,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
26,598 |
|
|
|
21,831 |
|
|
|
18,499 |
|
|
|
13,621 |
|
|
|
8,727 |
|
Research and development expenses |
|
|
5,089 |
|
|
|
3,619 |
|
|
|
2,677 |
|
|
|
2,748 |
|
|
|
2,837 |
|
Selling, general and administrative
expenses |
|
|
16,363 |
|
|
|
15,927 |
|
|
|
14,237 |
|
|
|
13,530 |
|
|
|
16,588 |
|
Customer deposit forfeiture (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,000 |
) |
|
|
(1,000 |
) |
Loss on extinguishment of convertible
debt (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
255 |
|
|
|
871 |
|
Interest expense |
|
|
22 |
|
|
|
21 |
|
|
|
|
|
|
|
171 |
|
|
|
1,126 |
|
Gain on derivatives (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,043 |
) |
Income tax (benefit) expense to
continuing operations (4) |
|
|
(35,500 |
) |
|
|
67 |
|
|
|
42 |
|
|
|
181 |
|
|
|
(60 |
) |
Income (loss) from continuing operations |
|
|
40,720 |
|
|
|
2,411 |
|
|
|
2,149 |
|
|
|
(724 |
) |
|
|
(6,739 |
) |
Basic income (loss) per common share from
continuing operations |
|
$ |
0.63 |
|
|
$ |
0.04 |
|
|
$ |
0.03 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.12 |
) |
Diluted income (loss) per common share
from continuing operations |
|
$ |
0.61 |
|
|
$ |
0.04 |
|
|
$ |
0.03 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.12 |
) |
Shares used in computing basic income
(loss) per common share |
|
|
64,401 |
|
|
|
63,422 |
|
|
|
62,982 |
|
|
|
60,424 |
|
|
|
57,068 |
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
2007 |
|
|
2006 |
|
|
|
(In thousands, except per share data) |
|
Shares used in computing diluted income
(loss) per common share |
|
|
66,742 |
|
|
|
64,051 |
|
|
|
65,856 |
|
|
|
60,424 |
|
|
|
57,068 |
|
Statements of Cash Flows Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows provided by (used for): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
7,190 |
|
|
$ |
603 |
|
|
$ |
2,064 |
|
|
$ |
(1,443 |
) |
|
$ |
(16,678 |
) |
Investing activities |
|
|
(1,467 |
) |
|
|
(1,138 |
) |
|
|
493 |
|
|
|
(3,155 |
) |
|
|
3,914 |
|
Financing activities |
|
|
5,609 |
|
|
|
577 |
|
|
|
164 |
|
|
|
2,339 |
|
|
|
5,307 |
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, Cash Equivalents and Marketable
Securities |
|
$ |
24,619 |
|
|
$ |
13,312 |
|
|
$ |
13,245 |
|
|
$ |
12,258 |
|
|
$ |
12,783 |
|
Working capital (deficit)(5) |
|
|
9,822 |
|
|
|
(3,283 |
) |
|
|
(3,010 |
) |
|
|
(979 |
) |
|
|
(897 |
) |
Total assets |
|
|
66,852 |
|
|
|
19,748 |
|
|
|
19,357 |
|
|
|
19,474 |
|
|
|
20,366 |
|
Debt obligations |
|
|
186 |
|
|
|
312 |
|
|
|
|
|
|
|
|
|
|
|
2,916 |
|
Stockholders equity (deficit) |
|
|
46,887 |
|
|
|
(1,989 |
) |
|
|
(1,303 |
) |
|
|
(289 |
) |
|
|
927 |
|
|
|
|
|
|
Operations Data in the preceding table excludes all activity of the discontinued
operations. |
|
(1) |
|
A Master Services Agreement was entered into with sanofi-aventis for $4.0
million in January 2004 calling for our performance on various future services to be
defined over the course of the agreement. Because the services to be provided to
sanofi-aventis had not been defined, the payment was recorded as a customer deposit. Because sanofi-aventis
failed to define or request services as the contracted delivery dates expired in 2005, 2006,
and 2007, the corresponding customer deposit was classified as a forfeiture. |
|
(2) |
|
The $255,000 loss on extinguishment of debt in 2007 resulted from the
restructuring of a note with sanofi-aventis. The $871,000 loss on extinguishment of debt in
2006 resulted from the retirement of a $5.0 million convertible promissory note
payable. |
|
(3) |
|
The $4.0 million gain in derivative in 2006 resulted from our April 2006
private placement of common stock. Associated warrants related to this private placement
were classified as derivative liabilities. Revaluations to the fair value of these warrants
were recorded as gain or loss to the statement of operations until new FASB guidance in
December 2006 required these components be prospectively adjusted to additional paid in
capital. |
|
(4) |
|
The $35.5 million tax benefit in 2010 resulted from the release of a portion
of our deferred tax asset valuation allowance. Based on analysis of both projected and
current earnings excluding discontinued operations, we have estimated these tax credits as
likely to be utilized prior to expiration. See Income Taxes in Item 7. Managements
Discussion and Analysis of Financial Condition and Results of Operations. |
|
(5) |
|
Working capital includes deferred revenue totaling $15.3 million, $14.5
million, $15.0 million, $12.6 million and $8.4 million as of December 31, 2010, 2009, 2008,
2007, and 2006 respectively. Working capital also includes customer deposits totaling $2.0
million as of December 31, 2006. |
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
The following discussion and analysis contains forward-looking statements about trends,
uncertainties and our plans and expectations of what may happen in the future. Forward-looking
statements involve risks and uncertainties that could cause actual events or results to differ
materially from the events or results described in the forward-looking statements, including risks
and uncertainties described above in Item 1A. Risk Factors. Readers are cautioned not to place
undue reliance on forward-looking statements. The forward-looking statements are based upon
information available to us on the date of this report. We undertake no obligation to publicly
update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise.
Overview
We are a leader in providing secure, email encryption in a SaaS model. Our email encryption
service delivers information in a secure manner, enabling the use of Internet based email for the
safe delivery of sensitive information, especially for the healthcare, finance, insurance, and
government sectors. A core competency is our ability to deliver this complex service offering with
a high level of availability, reliability, integrity and security.
The Company is encouraged by 2010 results and our success is based on continuing to build a
solid and predictable business based on our successful subscription business model. Additionally,
our results indicate we are transitioning to become a part of mainstream demand for email
encryption as data security and integrity issues
17
continue to make headline news. We are also
benefiting from a trend toward the use of a powerful cloud-based offering along with the growing
need for regulatory compliance.
We achieved our first ever full year GAAP net income in 2010 and we successfully wound down
the e-Prescribing business as planned on December 31, 2010. All of our key performance
metrics improved compared to the prior year and we reported improved financial performance
driven by continued growth in our Email Encryption business and the successful exit from
e-Prescribing. The Companys operating income for 2010 was $5.1 million, an increase of $2.9
million over prior year, driven by 25% growth in revenue.
Strategy and Focus Areas
The Companys email encryption subscription service continued to grow in 2010 by adding new
customers while retaining a high percentage of existing customers. Our subscription model
initially required large up-front investment to establish the service, but over time, the fixed
set-up costs are exceeded by the recurring subscription and transaction fees, and incremental costs
to add new users are relatively low. After the years required to achieve critical mass in the Email
Encryption business with the subscription model, combined with the successful wind down of the
e-Prescribing business, we believe we entered a new phase of financial stability in 2010.
Over the course of 2010 we continued to make investments to strengthen our Email Encryption
services by completing development of and releasing a number of service upgrades. We delivered
ZixGateway 4.0, an upgrade to our policy-based appliance that provides support for virtualization,
multiple languages and DomainKeys Identified Mail (DKIM). We also completed and released ZixPort
3.7, an upgrade to our portal-based service which provides language localization, increased large
file support and support for the iPhone®. We updated our software platform for the
desktop client portfolio to align with recent computing technology evolution and advancements and
delivered new versions which are aligned to Microsoft® Office 2010. In addition, we
designed a set of tools to improve the automation level and efficiency of the customer provisioning
process for our resellers and distributors. This will allow our third-party channels to deploy our
service more quickly and at lower cost.
Operationally, our success is primarily dependent upon the following key metrics:
|
|
|
New subscriptions (termed New First Year Orders (NFYO)) for the Email Encryption
Service; |
|
|
|
|
Retention of subscribers to the Email Encryption Service; |
|
|
|
|
Total orders (includes NFYOs, second and third years on multi-year orders and
renewals), and; |
|
|
|
|
Our ability to increase business volume with minimal cost increases. |
Known trends regarding these key metrics and their implication on our current and future
capital requirements are discussed throughout this Managements Discussion and Analysis of
Financial Condition and Results of Operations (MD&A).
There are no assurances we will be successful in our efforts to achieve these key metrics. Our
continued growth depends on the timely development and market acceptance of our products and
services. Driven primarily by the growth of the Email business combined with improved financial
results associated with the wind down of the e-Prescribing business, we have improved fundamentals
in our cash and achieved GAAP profitability in 2010. See Item 1A. Risk Factors for more
information on the risks relative to our operations and future prospects.
Discontinued Operations
On December 31, 2010, Zix Corporation completed the previously announced (see Current Report
filed on Form 8-K/A dated January 6, 2010) wind down of its e-Prescribing business and
discontinued operating this line of business. The wind down of this business entailed the fulfillment of existing contracts. Assets
used by this segment, primarily business computer servers, were compatible with the remaining
business, Email Encryption, and were therefore absorbed by our remaining business. As a result, no
gain or loss on disposal of assets was incurred. Prior to the completion of the wind down, this
business line had been a reportable segment. The following table summarizes the components of the
Income (loss) from discontinued operations presented in our Statement of Operations for 2010, 2009
and 2008.
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Revenues |
|
$ |
2,632,000 |
|
|
$ |
4,244,000 |
|
|
$ |
5,431,000 |
|
Cost of revenues |
|
|
1,266,000 |
|
|
|
4,808,000 |
|
|
|
5,745,000 |
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
1,366,000 |
|
|
|
(564,000 |
) |
|
|
(314,000 |
) |
Research and development expenses |
|
|
300,000 |
|
|
|
3,329,000 |
|
|
|
3,481,000 |
|
Selling, general and administrative expenses |
|
|
304,000 |
|
|
|
2,953,000 |
|
|
|
3,796,000 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
762,000 |
|
|
$ |
(6,846,000 |
) |
|
$ |
(7,591,000 |
) |
|
|
|
|
|
|
|
|
|
|
In December of 2009, the Company announced it would wind down the e-Prescribing business and
exit the business by December 31, 2010. During 2010 we reduced the costs of operating this
business and transferred shared resources to the remaining business while meeting the requirements
of our existing contracts. We also discontinued our recruiting efforts for new e-Prescribing
deployments and reduced the associated recruitment and deployment expenses. Additionally,
customers requesting to renew existing contracts set to expire during 2010 were renewed to
terminate no later than December 31, 2010. These actions resulted in significantly lower costs and
lower revenue in 2010 compared to 2009 and 2008 for the e-Prescribing business. The 2010 income
before income taxes of $762,000 resulted primarily from the continued recognition of deferred
revenue during the year while reducing expenses in cost of revenues, research and development, and
SG&A.
Unless specifically noted, the financial information contained and discussed in our MD&A is
that of our continuing operations only.
Revenue
Revenue increased by 25% in 2010 compared with 2009. Our growth was driven by our successful
subscription model that continues to yield steady additions to the subscriber base coupled with a
high rate of renewing existing customers.
Operating Margins
For the year ended 2010, our gross profit of $26.6 million increased 22% compared to 2009.
This increase was primarily driven by increased revenue. Our 2010 operating income of $5.1 million
improved $2.9 million over the prior year. Income from continuing operations for 2010
included a $35.3 million reduction to the Companys deferred tax asset valuation allowance.
This reduction was recorded as a tax benefit in 2010. Income from continuing operations for 2010
excluding the impact of this tax benefit was $5.2 million compared to $2.5 million in 2009.
Other Financial Highlights
|
|
|
We completed our exit from the e-Prescribing business. Our Statements of Operations
have been reclassified to reflect the impact of the discontinued e-Prescribing operation |
|
|
|
|
Email Encryption backlog was $49.9 million in 2010, compared with $42.9 at the end of
2009 |
|
|
|
|
Total orders for 2010 were $40.8 million, an increase of 16% from the 2009 total orders
of $35.2 million |
|
|
|
|
Our deferred revenue at the end of 2010 was $16.8 million, compared with $17.3 million
at the end of 2009 (2009 deferred revenue included $1.2 million related to the discontinued
e-Prescribing segment) |
|
|
|
|
We generated cash flows from operations of $7.2 million during fiscal 2010. Our cash
and cash equivalents were $24.6 million at the end of 2010, compared with $13.3 million at
the end of 2009 |
|
|
|
|
Our shared, cloud-based ZixDirectory now has approximately 25 million members including
some of the most respected institutions in the country |
19
Critical Accounting Policies and Estimates
In preparing our consolidated financial statements, we make estimates, assumptions and
judgments that can have a significant impact on revenue, income (loss) from operations and net
income (loss), as well as the value of certain assets and liabilities on our consolidated balance
sheet. The application of our critical accounting policies requires an evaluation of a number of
complex criteria and significant accounting judgments by us. Management bases its estimates on
historical experience and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. We evaluate our estimates on a regular basis and make changes
accordingly. Senior management has discussed the development, selection and disclosure of these
estimates with the Audit Committee of our Board of Directors. Actual results may materially differ
from these estimates under different assumptions or conditions. If actual results were to differ
from these estimates materially, the resulting changes could have a material adverse effect on the
consolidated financial statements.
An accounting policy is deemed to be critical if it requires an accounting estimate to be made
based on assumptions about complex matters that are highly uncertain at the time the estimate is
made, and if different estimates that reasonably could have been used, or changes in the accounting
estimates that are reasonably likely to occur periodically, could materially impact the
consolidated financial statements. Management believes the following critical accounting
policies reflect our more significant estimates and assumptions used in the preparation of the
consolidated financial statements.
Our critical accounting policies included the following:
|
|
|
Revenue recognition |
|
|
|
|
Income taxes |
|
|
|
|
Valuation of goodwill and other intangible assets |
|
|
|
|
Stock-based compensation costs |
For additional discussion of the Companys significant accounting policies, refer to Note 2 to
the consolidated financial statements.
Revenue Recognition
We develop, market, and support applications that connect, protect and deliver information in
a secure manner. Our services can be placed into several key revenue categories where each category
has similar revenue recognition traits: Email Encryption subscription-based services, various
transaction fees and related professional services. The majority of the revenues generated are
through a combination of direct sales and a network of resellers and other distribution partners.
Under all product categories and distribution models, we recognize revenue after all of the
following occur:
|
|
|
persuasive evidence of an arrangement exists, |
|
|
|
|
delivery has occurred or services have been rendered, |
|
|
|
|
the price is fixed and determinable, and |
|
|
|
|
collectability is reasonably assured. |
When we are engaged in a complex product deployment, customer acceptance may have to occur
before the transaction is considered complete. In this situation, no revenue is recognized until
the customer accepts the product. Discounts provided to customers are recorded as reductions in
revenue.
Our email encryption service is a subscription service. Providing this service includes
delivering subscribed-for software and providing secure electronic communications and customer
support throughout the subscription period. Our email subscribers generally execute multiple-year
contracts that are irrevocable and non-refundable in nature and require annual, up-front payments.
Subscription fees received from customers are initially recorded as deferred revenue and then
recognized as revenue ratably over the subscription period. We do not offer stand alone services.
Further, our services primarily include manufacturer provided warranty provisions. We recorded no
warranty expense in any of the presented periods.
20
The discontinued e-Prescribing service was also a subscription service. Some of these
services incorporated transaction fees per event occurrence or when predetermined usage levels
had been reached. These transaction fees were recognized as revenue when the transaction
occurred or when a predetermined usage level had been achieved, and when the amounts were fixed and
determinable.
Income Taxes
Deferred tax assets are recognized if it is more likely than not that the benefit of the
deferred tax asset will be realized on future federal income tax returns. At December 31, 2010, we
provided a valuation allowance against a significant portion of our accumulated U.S. deferred tax
assets of $75,352,000. This significant valuation allowance reflects our historical losses and the
uncertainty of future taxable income sufficient to utilize net operating loss carryforwards prior
to their expiration. Our total deferred tax asset not subject to a valuation allowance is valued at
$35,360,000, and consists of $35,300,000 for net operation loss carryforwards and $48,000 for U.S.
state income tax credits and $12,000 for a Canadian deferred tax asset relating to temporary timing
differences between GAAP and tax-related expense. If U.S. taxable income increases from its current
level in a future period or if the facts and circumstances on which our estimates and assumptions
are based were to change, thereby impacting the likelihood of realizing the deferred tax assets,
judgment would have to be applied in determining the amount of valuation allowance no longer
required. Reversal of all or a part of this valuation allowance could have a significant positive
impact on operating results in the period that it becomes more likely than not that certain of the
Companys deferred tax assets will be realized.
The Company previously recorded a $327,000 tax contingency liability related to tax year 2004,
and that amount and the specifics therein have remained unchanged except for currency translation
adjustments. As of December 31, 2010, the gross amount of our unrecognized tax benefits, inclusive
of the $327,000 tax liability and $50,000 in other uncertain positions in 2008, was approximately
$461,000. Included in this balance are tax positions which, if recognized, would impact our
effective tax rate.
Valuation of Goodwill and Other Intangible Assets
We account for the valuation of goodwill and other intangible assets after classifying
intangible assets into three categories: (1) intangible assets with finite lives subject to
amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3)
goodwill. For intangible assets with finite lives, tests for impairment must be performed if
conditions exist that indicate that the carrying value may not be recoverable. For intangible
assets with indefinite lives and goodwill, tests for impairment must be performed at least annually
or more frequently if events or circumstances indicate that assets might be impaired.
Goodwill was $2,161,000, or 3% of total assets at December 31, 2010; and was $2,161,000, or
11% of total assets at December 31, 2009.
Our goodwill is not being amortized, but we do evaluate the goodwill for impairment annually
in the fourth quarter, or when there is reason to believe that the value has been diminished or
impaired. Evaluations for possible impairment are based upon a comparison of the estimated fair
value of the reporting unit to which the goodwill has been assigned to, versus the sum of the
carrying value of the assets and liabilities of that unit including the assigned goodwill
value. The fair values used in this evaluation are estimated based on the Companys market
capitalization, which is based on the outstanding stock and market price of the stock. Impairment
is deemed to exist if the net book value of the unit exceeds its estimated fair value. We have
evaluated our goodwill and determined no impairment is required.
Stock-based Compensation
We have non-qualified stock options outstanding to employees, directors, and third parties
under various stock option plans. The plans require the exercise price of options granted under
these plans to equal or exceed the fair market value of the Companys common stock on the date of
grant. The options, subject to termination of employment, generally expire ten years from the date
of grant. Employee options generally vest pro-rata and quarterly over three years. Option grants to
employees, officers and directors frequently contain accelerated vesting provisions upon the
occurrence of a change of control, as defined in the applicable option agreements. We currently
21
use the straight-line amortization method for recognizing stock option compensation costs. For
periods prior to January 1, 2006, we used the intrinsic value method to account for stock-based
compensation plans. Our share-based awards are limited to stock options.
Full Year 2010 Summary of Operations
Financial
|
|
|
We completed our exit from the e-Prescribing business. Our income statement has been
reclassified to reflect the impact of the discontinued e-Prescribing operation. |
|
|
|
|
Revenue for 2010 was $33,066,000 compared with $26,407,000 in 2009 and $22,604,000 in
2008. |
|
|
|
|
Gross margin for 2010 was $26,598,000 or 80% of revenues compared to $21,831,000 or 83%
of revenues in 2009 and $18,499,000 or 82% of revenues in 2008. |
|
|
|
|
Income from continuing operations for the year 2010 was $40,720,000 compared with
income from continuing operations of $2,411,000 in 2009 and $2,149,000 in 2008. |
|
|
|
|
Net income for the year 2010 was $41,213,000 compared with net loss of $4,435,000 in
2009 and $5,442,000 in 2008. Included in Net income for 2010 was a reduction in our
deferred tax asset valuation allowance of $35,300,000 which was recorded as a tax benefit. |
|
|
|
|
Ending unrestricted cash was $24,619,000 on December 31, 2010. |
Results of Operations
Revenue
The following table sets forth a year-over-year comparison of our total revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variance |
|
Variance |
|
|
Year Ended December 31, |
|
|
2010 vs. 2009 |
|
|
2009 vs. 2008 |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Revenues |
|
$ |
33,066,000 |
|
|
$ |
26,407,000 |
|
|
$ |
22,604,000 |
|
|
$ |
6,659,000 |
|
|
|
25 |
% |
|
$ |
3,803,000 |
|
|
|
17 |
% |
Revenue increases were driven primarily by strong performances across our three core
vertical sales markets: healthcare, finance and government and other non-core markets.
Additionally, sales came from a wider base of distributors new first year orders derived from
our value added resellers, OEM and third party distribution channels for 2010 was 53% of the total
NFYO compared to 33% in 2009. Our growth model seeks to continually add new users to the
subscriber base, while at the same time retaining a high percentage of existing subscribers whose
subscriptions are up for renewal. We measure additions to the subscriber base by NFYO, which is
defined as the portion of new orders that are expected to be recognized into revenue in the first
twelve months of the contract. NFYOs are summarized in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
New first year order value |
|
$ |
8,670,000 |
|
|
$ |
6,478,000 |
|
|
$ |
5,460,000 |
|
Our go-to-market selling strategy seeks primarily multiple-year subscription contracts with
the fees paid annually at the inception of each year of service. As a result, a high percentage of
customers subscribe to the Email Encryption Service for a three-year term versus a one-year term.
We expect this preference for a longer contract term by a high percentage of our customers to
continue in 2011, as we have priced our services in a manner that encourages longer-term
contractual commitments from customers.
Our list pricing for Email Encryption has remained generally consistent during the periods
shown above. We have continued to experience some market pricing pressure resulting in additional
discount percentages off our list price during this period. There are no assurances that potential
increased competition in this market or other factors will not result in future price erosion.
Price erosion, should it occur, could have a dampening effect on our new orders.
22
Revenue Outlook:
With our continued focus in Email Encryption on sectors such as healthcare, financial
services, insurance, government, and expansion into other non-core markets, along with the
increased use of indirect OEM distribution and value-added reseller channels, we expect to see the
business increase its new first year orders in 2011 and fuel a continued increase in our
year-over-year revenue.
Backlog and Orders
Backlog Our end-user order backlog is comprised of contractually bound agreements that we
expect to amortize into revenue. As of December 31, 2010, the backlog was comprised of the
following elements: $16,770,000 of deferred revenue that has been billed and paid, $5,168,000
billed but unpaid net, and approximately $27,973,000 of unbilled contracts.
The backlog is recognized into revenue as the services are performed. Approximately 55% of the
total backlog is expected to be recognized as revenue during the next twelve months. The timing of
revenue is affected by both the length of time required to deploy a service and the length of the
service contract.
Orders Total order input for Email Encryption in 2010 was $40,763,000 compared with
$35,190,000 in 2009. Total orders include customer orders that management separates into three
components for measurement purposes: contract renewals, NFYOs, and in the case of new multi-year
contracts, the years beyond the first year of service.
Cost of Revenues
The following table sets forth a year-over-year comparison of the cost of revenues.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variance |
|
Variance |
|
|
Year Ended December 31, |
|
|
2010 vs. 2009 |
|
|
2009 vs. 2008 |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Cost of revenues |
|
$ |
6,468,000 |
|
|
$ |
4,576,000 |
|
|
$ |
4,105,000 |
|
|
$ |
1,892,000 |
|
|
|
41 |
% |
|
$ |
471,000 |
|
|
|
11 |
% |
Cost of revenues is comprised of costs related to operating and maintaining the ZixData
Center, a field deployment team, customer service and support and the amortization of
Company-owned, customer-based computer appliances. For Email Encryption, a significant portion of
the total cost of revenues relates to the ZixData Center, which currently has excess capacity.
Accordingly, cost of revenues is relatively fixed in nature and is expected to grow at a slower
pace than revenue. During 2010, we transitioned a significant amount of shared resources from our
e-Prescribing product line resulting from the wind down of that business. Additionally, we shifted
fixed costs that were previously absorbed by e-Prescribing. The cost of revenues increase in 2010
compared to 2009 resulting from this shifting of shared resource costs and allocated fixed costs
was approximately $1,750,000. The remaining increase in cost of revenues in 2010 compared to 2009,
approximately $150,000, resulted from growth in revenue, primarily costs associated with deploying
and supporting the email encryption service.
The increase in cost of revenues in 2009 compared to 2008 resulted primarily from growth in
revenue, and costs associated with deploying and supporting the email encryption service.
Research and Development Expenses
The following table sets forth a year-over-year comparison of our research and development
expenses from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variance |
|
Variance |
|
|
Year Ended December 31, |
|
|
2010 vs. 2009 |
|
|
2009 vs. 2008 |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Research and development expenses |
|
$ |
5,089,000 |
|
|
$ |
3,619,000 |
|
|
$ |
2,677,000 |
|
|
$ |
1,470,000 |
|
|
|
41 |
% |
|
$ |
942,000 |
|
|
|
35 |
% |
Research and development expenses consist primarily of salary, benefits and stock-based
compensation for our development staff, and other costs associated with improving our existing
products and services and developing new products and services. The increase in research and
development expense in 2010 compared to 2009 resulted
23
primarily from a $150,000 increase in
salaries and benefits resulting from increases in average headcount and approximately $1,320,000
increase resulting primarily from the shift from the e-Prescribing business of shared resources and
shift in allocated fixed costs. During 2010 we wound down the e-Prescribing operation and shifted
previously shared resources to the remaining business, Email Encryption.
Additionally, we shifted fixed expenses previously absorbed by e-Prescribing to Email
Encryption.
The increase in research and development expense in 2009 compared to 2008 was primarily
attributable to a $535,000 increase in salary and benefit expense resulting from an increase in
average headcount and salary increases, an $83,000 increase in stock-based compensation expense,
and an increase of $324,000 resulting primarily from directing a higher percentage of research and
engineering resources to Email Encryption in the second half of 2009.
Selling, General and Administrative Expenses
The following table sets forth a year-over-year comparison of our selling, general and
administrative expenses from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variance |
|
Variance |
|
|
Year Ended December 31, |
|
|
2010 vs. 2009 |
|
|
2009 vs. 2008 |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Selling, general
and administrative
expenses |
|
$ |
16,363,000 |
|
|
$ |
15,927,000 |
|
|
$ |
14,237,000 |
|
|
$ |
436,000 |
|
|
|
3 |
% |
|
$ |
1,690,000 |
|
|
|
12 |
% |
Selling, general and administrative expenses consist primarily of salary, commissions,
travel, stock-based compensation and benefits for marketing, selling and executive and
administrative personnel. Also included are costs associated with advertising and promotions and
fees for professional services and other general corporate activities. The increase in 2010
compared to 2009 resulted primarily from higher marketing expenses, sales commissions and travel
expenses due to growth in the business. These increases were partially offset by lower severance
and professional fees, both related to the wind down of the e-Prescribing business.
Selling, general and administrative expenses in 2009 compared to 2008 increased $1,690,000.
This increase was primarily the result of higher salaries and benefits, primarily related to
severance costs of $600,000, increased professional fees of $660,000, of which approximately
$300,000 related to a non-recurring strategic review of the Companys e-Prescribing business, and
stock-based compensation expense of $380,000. The remaining net increase, $50,000, resulted from
other net increases and decreases in the various selling, general and administrative expense
categories.
Total selling, general and administrative expenses for 2011 are expected to increase slightly
compared to the 2010 levels due to continued investment in our sales and marketing resources.
Interest Expense
Interest expense for 2010 and 2009 was $22,000 and $21,000 respectively, consisting of
interest related to a license subscription promissory note payable. We incurred no interest
expense in 2008.
Investment and Other Income
Investment and other income was $96,000, $214,000 and $606,000 for the years ended December
31, 2010, 2009 and 2008, respectively. The decreasing amounts in all years presented was primarily
driven by lower interest rates.
Income Taxes
Our Company or one of our subsidiaries files income tax returns in the U.S. federal
jurisdiction and various states and in the Canadian federal and provincial jurisdictions. We
recognize and measure uncertain tax positions using a two-step approach. The first step is to
evaluate the tax position for recognition by determining if the weight of available evidence
indicates that it is more likely than not that the position will be sustained on audit, including
24
resolution of related appeals or litigation processes, if any. The second step is to measure the
tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.
The Companys income tax (benefit) expense for 2010, 2009 and 2008 of ($35,231,000), $67,000
and $42,000, respectively, represents refundable U.S. research and development credits, non-U.S.
taxes payable related to the operations of the Companys Canadian subsidiary established in late
2002, state income taxes, and reversal of a portion of the Companys historical valuation
allowance.
Significant judgment is required in determining any valuation allowance recorded against
deferred tax assets. In assessing the need for a valuation allowance, we consider available
evidence, including past earnings, estimates of future taxable income, and the feasibility of tax
planning strategies. At December 31, 2010, the Company partially reserved its U.S. net deferred tax
assets due to the uncertainty of future taxable income sufficient to utilize net loss carryforwards
prior to their expiration. The portion of the Companys deferred tax asset not reserved was
$35,348,000. This unreserved portion related to $35,300,000 U.S. net operating losses (NOLs)
because we believe the Company will generate sufficient taxable income in future years to utilize
these NOLs prior to their expiration. The remaining $48,000 related to state tax credit
carryforwards because such credits will be used to offset revenue-based state franchise tax.
We have determined that utilization of existing net operating losses against future taxable
income is not limited by Section 382 of the Internal Revenue Code. Future ownership changes,
however, may limit the Companys ability to fully utilize its existing net operating loss
carryforwards against any future taxable income.
If we begin to generate additional U.S. taxable income in a future period or if the facts and
circumstances on which our current estimates and assumptions are based were to change, thereby
impacting the likelihood of realizing a greater or lesser amount of our deferred tax assets,
judgment would have to be applied in determining the amount of valuation allowance required.
Adjusting our valuation allowance could have a significant positive impact on operating results in
the period that it becomes more likely than not that an additional portion of our deferred tax
assets will or will not be realized.
Our provision for income taxes is subject to volatility and could be adversely impacted by
earnings being lower or higher than anticipated; by tax effects of nondeductible compensation; or
by changes in tax laws, regulations, or accounting principles, including accounting for uncertain
tax positions or interpretations. Significant judgment is required to determine the recognition and
measurement applicable to all income tax positions. This includes the potential recovery of
previously paid taxes, which if settled unfavorably could adversely affect our provision for income
taxes or additional paid-in capital. In addition, we are subject to examination of our income tax
returns by the Internal Revenue Service and other tax authorities. We regularly assess the
likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our
provision for income.
Net Income (Loss)
Income from continuing operations In 2010, the Companys Income from continuing operations
was $40,720,000 compared to $2,411,000 and $2,149,000 in 2009 and 2008, respectively. The 2010
amount included a tax benefit of $35,500,000 resulting from a decrease in the deferred tax
valuation allowance.
Income (loss) from discontinued operations In 2010, Income from discontinued operations was
$493,000 compared to losses of ($6,846,000) and ($7,591,000) in 2009 and 2008, respectively. The
income improvement in 2010 compared to 2009 and 2008 resulted primarily from recognizing remaining
deferred revenue during the wind down when most of the costs associated with the discontinued
e-Prescribing business had been eliminated or transferred to the remaining business, Email
Encryption.
Net Income (loss) The Company achieved its first ever annual Net income of $41,213,000 in
2010 compared to net losses of ($4,435,000) and ($5,442,000) in 2009 and 2008, respectively. The
net income in 2010 included a tax benefit of $35,300,000 resulting from a decrease in the Companys
deferred tax asset valuation allowance. The following table summarizes this and other unusual
components included in the net income (loss) for these three years.
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Unusual Items: |
|
|
|
|
|
|
|
|
|
|
|
|
Non-recurring severance payments |
|
$ |
262,000 |
|
|
$ |
1,451,000 |
|
|
$ |
|
|
Decrease in the deferred tax asset valuation allowance |
|
|
(35,300,000 |
) |
|
|
|
|
|
|
|
|
Expenses related to the strategic review of the
e-Prescribing business |
|
|
|
|
|
|
393,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total unusual items |
|
$ |
(35,038,000 |
) |
|
$ |
1,844,000 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
Liquidity and Capital Resources
Overview
Based on our 2010 financial results and current expectations, we believe our cash and cash
equivalents, and cash generated from operations, will satisfy our working capital needs, capital
expenditures, investment requirements, contractual obligations, commitments, future customer
financings, and other liquidity requirements associated with our operations through at least the
next twelve months. We plan for and measure our liquidity and capital resources through an annual
budgeting process. At December 31, 2010, our cash and cash equivalents totaled $24.6 million and
debt was $186,000.
Prior to December 31, 2010, we operated two distinct business segments; Email Encryption and
e-Prescribing. During 2010, we wound down the e-Prescribing business and exited the business on
December 31, 2010. The remaining business, Email Encryption, is profitable and is expected to
continue to grow.
For the year ended December 31, 2010, we improved on record performance in the prior year and
achieved our best financial results to date. A 25% growth in revenue, 80% gross margin and strong
cash collections led to improved financial performance. This improvement was primarily driven from
increased revenues while holding our costs relatively flat. We expect this trend to continue in the
foreseeable future, and believe a significant portion of our spending is discretionary and flexible
and that we have the ability to adjust overall cash spending to react, as needed, to any shortfalls
in projected cash.
Sources and Uses of Cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Net cash provided by operations |
|
$ |
7,190,000 |
|
|
$ |
603,000 |
|
|
$ |
2,064,000 |
|
Net cash provided by (used in) investing activities |
|
$ |
(1,467,000 |
) |
|
$ |
(1,138,000 |
) |
|
$ |
493,000 |
|
Net cash provided by financing activities |
|
$ |
5,609,000 |
|
|
$ |
577,000 |
|
|
$ |
164,000 |
|
For 2010 and 2009, our primary source of liquidity from operations was the collection of
revenue in advance from our customers, accounts receivable from our customers, and the timing of
payments to our vendors and service providers. In 2008 we benefited by $1,200,000 from the issuance
of common stock to our employees in lieu of cash compensation. We did not continue this practice in
2009 and 2010 and do not expect to use this practice going forward.
Related
to our investing activities in 2010, we utilized $1,492,000 to purchase various
computing equipment primarily to satisfy customer contracts. Approximately 50% of these capital
purchases were for computer servers, which are required to deliver our services.
The cash provided from financing activities in 2010 was due to the exercise of stock options
and warrants.
Options and Warrants of ZixCorp Common Stock
We have significant warrants and options outstanding that are currently vested. There is no
assurance that any of these options and warrants will be exercised; therefore the extent of future
cash inflow from additional warrant and option activity is not certain. The following table
summarizes the warrants and options that are outstanding as of
26
December 31, 2010. The vested shares
are a subset of the outstanding shares. The value of the shares is the number of shares multiplied
by the exercise price for each share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Outstanding Options and Warrants |
|
|
|
|
|
|
|
|
|
|
|
Vested Shares |
|
|
|
|
|
|
|
|
|
|
Total Value of |
|
|
(included in |
|
|
|
|
|
|
Outstanding |
|
|
Outstanding |
|
|
outstanding |
|
|
Total Value of |
|
Exercise Price Range |
|
Shares |
|
|
Shares |
|
|
shares) |
|
|
Vested Shares |
|
$1.11 $1.99 |
|
|
4,142,168 |
|
|
$ |
6,370,000 |
|
|
|
3,841,090 |
|
|
$ |
5,901,000 |
|
$2.00 $3.49 |
|
|
1,200,648 |
|
|
|
3,124,000 |
|
|
|
904,389 |
|
|
|
2,499,000 |
|
$3.50 $4.99 |
|
|
2,884,115 |
|
|
|
12,780,000 |
|
|
|
2,868,916 |
|
|
|
12,714,000 |
|
$5.00 $5.99 |
|
|
515,927 |
|
|
|
2,624,000 |
|
|
|
515,927 |
|
|
|
2,624,000 |
|
$6.00 $8.99 |
|
|
620,816 |
|
|
|
4,052,000 |
|
|
|
620,816 |
|
|
|
4,052,000 |
|
$9.00 $13.00 |
|
|
861,881 |
|
|
|
9,205,000 |
|
|
|
861,881 |
|
|
|
9,205,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
10,225,555 |
|
|
$ |
38,153,000 |
|
|
|
9,613,019 |
|
|
$ |
36,995,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquidity Summary
Based on our current 2011 budget plans, we believe we have adequate resources and liquidity to
sustain operations for the next twelve months.
Off-Balance Sheet Arrangements
None.
Contractual Obligations and Contingent Liabilities and Commitments
We have total contractual obligations over the next year of $1,438,000 and $3,333,000 over the
next three years primarily consisting of various operating office lease agreements.
A summary of our fixed contractual obligations and commitments at December 31, 2010, is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period |
|
|
|
Total |
|
|
1 Year |
|
|
2-3 Years |
|
|
4-5 Years |
|
|
> 5 Years |
|
Operating leases |
|
$ |
3,800,000 |
|
|
$ |
1,290,000 |
|
|
$ |
1,845,000 |
|
|
$ |
665,000 |
|
|
$ |
|
|
License subscription note payable |
|
|
198,000 |
|
|
|
148,000 |
|
|
|
50,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,998,000 |
|
|
$ |
1,438,000 |
|
|
$ |
1,895,000 |
|
|
$ |
665,000 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We have severance agreements with certain employees which would require us to pay
approximately $1,554,000 if all such employees separated from employment with our Company following
a change of control, as defined in the severance agreements.
New Accounting Standards
Revenue Recognition
In October 2009, the Financial Accounting Standards Board (FASB) issued guidance on
revenue recognition that becomes effective January 1, 2011, with earlier adoption permitted. Under
the new guidance tangible products that have software components that are essential to the
functionality of the tangible product will no longer be within the scope of the software revenue
recognition guidance; such software-enabled products will now be subject to other relevant revenue
recognition guidance. Additionally, the FASB issued authoritative guidance on revenue arrangements
with multiple deliverables that are outside the scope of the software revenue recognition guidance.
Under the new guidance, when vendor specific objective evidence (VSOE) or third party evidence
for deliverables in an arrangement cannot be determined, a best estimate of the selling price is
required to separate deliverables and allocate arrangement consideration using the relative selling
price method. The new guidance includes new disclosure requirements on how the application of the
relative selling price method affects the timing and amount of revenue recognition. We do not
anticipate that this new guidance will have a material impact on our consolidated financial
statements.
27
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We do not believe that we face exposure to material market risk with respect to our cash, cash
equivalents and restricted cash investments, which totaled $24,619,000 and $13,287,000 at December
31, 2010 and 2009, respectively. We held no marketable securities as of December 31, 2010, and held
$25,000 in marketable securities as of December 31, 2009.
At December 31, 2010, we had a $186,000 non-interest bearing note payable with an imputed
interest rate of 8.6% (see note 12 to the consolidated financial statements).
Item 8. Financial Statements and Supplementary Data
The information required by this Item 8 begins on page F-1 of this Annual Report.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Effectiveness of Disclosure Controls and Procedure
In accordance with Rule 13a-15(b) of the Exchange Act, as of the end of the period covered by
this Annual Report on Form 10-K, management evaluated, with the participation of our principal
executive officer and principal accounting officer, the effectiveness of the design and operation
of the Companys disclosure controls and procedures (as defined in Rule 13a-15(e) under the
Exchange Act). Based on their evaluation of these disclosure controls and procedures, they have
concluded that our disclosure controls and procedures were effective as of the date of such
evaluation.
Certifications of our principal executive officer and our principal accounting officer, which
are required in accordance with Rule 13a- 14 of the Exchange Act, are attached as exhibits to this
Annual Report. This Controls and Procedures section includes the information concerning controls
evaluation referred to in the certifications, and it should be read in conjunction with the
certifications for a more complete understanding of the topics presented.
Managements Annual Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over
financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Because of its
inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to risk that controls may become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial reporting as of
December 31, 2010. In making this assessment, management used the criteria set forth by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal
ControlIntegrated Framework. Based on this assessment, our management concluded that, as of
December 31, 2010, our internal control over financial reporting was effective based on those
criteria.
The effectiveness of our internal control over financial reporting as of December 31, 2010,
has been audited by Whitley Penn LLP, an independent registered public accounting firm, as stated
in their report which is included herein.
28
Changes in Internal Controls over Financial Reporting
During the three months ended December 31, 2010, there have been no changes in our internal
control over financial reporting identified in connection with the evaluation described above that
have materially affected or are reasonably likely to materially affect internal control over
financial reporting.
29
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders
Zix Corporation
We have audited Zix Corporation and subsidiaries (the Company) internal control over financial
reporting as of December 31, 2010 based on criteria established in Internal ControlIntegrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The
Companys management is responsible for maintaining effective internal control over financial
reporting and for its assessment of the effectiveness of internal control over financial reporting
included in the accompanying Managements Report on Internal Control Over Financial Reporting. Our
responsibility is to express an opinion on the Companys internal control over financial reporting
based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control over financial reporting was
maintained in all material respects. Our audit of internal control over financial reporting
included obtaining an understanding of internal control over financial reporting, assessing the
risk that a material weakness exists, and testing and evaluating the design and operating
effectiveness of internal control based on the assessed risk. Our audit also included performing
such other procedures as we considered necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
companys internal control over financial reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
In our opinion, the Company maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2010, based on criteria established in Internal
ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), the consolidated balance sheets of the Company as of December 31, 2010 and
2009, and the related consolidated statements of operations, changes in stockholders equity
(deficit), and cash flows for each of the three years in the period ended December 31, 2010, and
our report dated March 10, 2011, expressed an unqualified opinion on those consolidated financial
statements.
/s/ WHITLEY PENN LLP
Dallas, Texas
March 10, 2011
30
Item 9B. Other Information
None.
31
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Certain information required by this Item 10 is incorporated by reference from our Proxy
Statement related to the 2011 Annual Meeting of Stockholders under the sections OTHER INFORMATION
YOU NEED TO MAKE AN INFORMED DECISION Directors, Executive Officers and Significant Employees
and Section 16(a) Beneficial Ownership Reporting Compliance, and CORPORATE GOVERNANCE Code of
Ethics, and Nominating and Corporate Governance Committee, Selection of Director Nominees, and
Audit Committee.
The board of directors has adopted a Code of Conduct and Code of Ethics that applies to all
directors, officers and employees of the Company. A copy of this document is available on our
website at www.zixcorp.com under Corporate Governance. Any waiver of the code of ethics with
respect to our chief executive officer and senior financial officers will be publicly disclosed as
required by applicable law and regulation, including by posting the waiver on our website.
Item 11. Executive Compensation
The information required by this Item 11, including certain information pertaining to Company
securities authorized for issuance under equity compensation plans, is incorporated by reference
from our Proxy Statement related to the 2011 Annual Meeting of Stockholders under the section
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
The information required by this Item 12 is incorporated by reference from our Proxy Statement
related to the 2011 Annual Meeting of Stockholders under the section SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT and COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS Equity
Compensation Plan Information.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this Item 13 is incorporated by reference from our Proxy Statement
related to the 2011 Annual Meeting of Stockholders under the section COMPENSATION OF DIRECTORS AND
EXECUTIVE OFFICERS Certain Relationships and Related Transactions and CORPORATE GOVERNANCE
Corporate Governance Requirements and Board Member Independence.
Item 14. Principal Accountant Fees and Services
The information required by this Item 14 is incorporated by reference from our Proxy Statement
related to the 2011 Annual Meeting of Stockholders under the section INDEPENDENT REGISTERED PUBLIC
ACCOUNTANTS.
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a)(1) Financial Statements
See Index to Consolidated Financial Statements on page F-1 hereof.
(a)(2) Financial Statement Schedules
All schedules for which provision is made in the applicable accounting regulations of the SEC
have been omitted because of the absence of the conditions under which they are required or because
the information required is included in the consolidated financial statements or notes thereto.
32
(a)(3) Exhibits
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
3.1
|
|
|
|
Restated Articles of Incorporation of Zix Corporation, as filed
with the Texas Secretary of State on November 10, 2005. Filed as
Exhibit 3.1 to Zix Corporations Annual Report on Form 10-K for
the year ended December 31, 2005, and incorporated herein by
reference. |
|
|
|
|
|
3.2
|
|
|
|
Amended and Restated Bylaws of Zix Corporation, dated February 4,
2009. Filed as Exhibit 3.1 to Zix Corporations Current Report on
Form 8-K, dated February 10, 2009, and incorporated herein by
reference. |
|
|
|
|
|
4.1
|
|
|
|
Specimen certificate for common stock of Zix Corporation. Filed as
Exhibit 4.1 to Zix Corporations Annual Report on Form 10-K for
the year ended December 31, 1999, and incorporated herein by
reference. |
|
|
|
|
|
4.2
|
|
|
|
Warrant to purchase 108,964 shares of common stock of Zix
Corporation re-issued to Iroquois Master Fund, Ltd., dated
December 17, 2007, which was originally issued by Zix Corporation
to Rodman & Renshaw, LLC., dated as of November 2, 2004 and filed
as Exhibit 4.2 to Zix Corporations Report on Form 8-K dated
December 29, 2006, and incorporated herein by reference. |
|
|
|
|
|
4.3
|
|
|
|
Form of Warrant, dated August 9, 2005, to purchase shares of
Common Stock of Zix Corporation (including appendices) (issued in
connection with a $26.3 million private placement in 2005). Filed
as Exhibit 4.2 to Zix Corporations Current Report on Form 8-K,
dated August 9, 2005, and incorporated herein by reference. |
|
|
|
|
|
4.4
|
|
|
|
Warrant, dated September 30, 2005, issued to Zix Corporation by
MITEM Corporation and exercisable for 400,000 shares of common
stock of MITEM Corporation issued in connection with the sale of
the Dr. Chart assets in 2005. Filed as Exhibit 2.3 to Zix
Corporations Current Report on Form 8-K, dated October 5, 2005,
and incorporated herein by reference. |
|
|
|
|
|
4.5
|
|
|
|
Form of Warrant, as of April 6, 2006, to purchase approximately
5.9 million shares of Common Stock of Zix Corporation (issued to
various purchasers in connection with an $11.8 million private
placement in 2006). Filed as Exhibit 4.2 to Zix Corporations
Report on Form 8-K dated April 5, 2006, and incorporated herein by
reference. |
|
|
|
|
|
4.6
|
|
|
|
Warrant, dated February 22, 2007, to purchase 145,853 shares of
Common Stock issued by Zix Corporation to sanofi-aventis, U.S.
Inc. issued in connection with the exchange of a promissory note
and issuance of a $1.6 million promissory note. Filed as Exhibit
4.3 to Zix Corporations Current Report on Form 8-K, dated
February 28, 2007, and incorporated herein by reference. |
33
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
4.7
|
|
|
|
Registration Rights Agreement, dated June 24, 2003, by and among
Zix Corporation and the investors named therein (issued in
connection with the $5.75 million financing). Filed as Exhibit 4.3
to Zix Corporations Current Report on Form 8-K, dated June 25,
2003, and incorporated herein by reference. |
|
|
|
|
|
4.8
|
|
|
|
Registration Rights Agreement, dated July 22, 2003, between Zix
Corporation and Pocket Script, L.L.C. Filed as Exhibit 4.2 to Zix
Corporations Current Report on Form 8-K, dated July 23, 2003, and
incorporated herein by reference. |
|
|
|
|
|
4.9
|
|
|
|
Registration Rights Agreement, dated January 30, 2004, by and
among Zix Corporation, Aventis Inc., a Pennsylvania corporation,
and Aventis Holdings Inc., a Delaware corporation. Filed as
Exhibit 4.2 to Zix Corporations Current Report on Form 8-K, dated
February 10, 2004, and incorporated herein by reference. |
|
|
|
|
|
4.10
|
|
|
|
Form of Registration Rights Agreement, dated as of November 2,
2004, by and between Zix Corporation and the Investors named
therein (issued in connection with a $20 million convertible note
private placement). Filed as Exhibit 4.5 to Zix Corporations
Current Report on Form 8-K, dated November 4, 2004, and
incorporated herein by reference. |
|
|
|
|
|
4.11
|
|
|
|
Form of Amended and Restated Registration Rights Agreement by and
between Zix Corporation and the Investors (excluding exhibits)
(issued in connection with a $20 million convertible note private
placement). Filed as Exhibit 4.5 to Zix Corporations Current
Report on Form 8-K, dated April 14, 2005, and incorporated herein
by reference. |
|
|
|
|
|
4.12
|
|
|
|
Securities Purchase Agreement, dated June 24, 2003, by and among
Zix Corporation and the investors named therein (including
schedules but excluding exhibits) in connection with a $5.75
million financing in 2003). Filed as Exhibit 4.1 to Zix
Corporations Current Report on Form 8-K, dated June 25, 2003, and
incorporated herein by reference. |
|
|
|
|
|
4.13
|
|
|
|
Securities Purchase Agreement, dated as of August 9, 2005, by and
between Zix Corporation and the Purchasers listed on Schedule A
thereto (including schedules, appendices and exhibits) (issued in
connection with a $26.3 million private placement in 2005). Filed
as Exhibit 4.1 to Zix Corporations Current Report on Form 8-K/A,
dated October 21, 2005, and incorporated herein by reference. |
|
|
|
|
|
4.14
|
|
|
|
Securities Purchase Agreement, dated as of April 4, 2006, by and
between Zix Corporation and the Purchasers listed on Schedule A
thereto (in connection with an $11.8 million private placement in
2006). Filed as Exhibit 4.1 to Zix Corporations Report on Form
8-K dated April 5, 2006, and incorporated herein by reference. |
|
|
|
|
|
4.15
|
|
|
|
Purchase Agreement, dated as of November 1, 2004, by and between
Zix Corporation and Omicron Master Trust (excluding schedules and
exhibits) in connection with a $20 million convertible note
financing in 2004). Filed as Exhibit 4.1 to Zix Corporations
Current Report on Form 8-K, dated November 4, 2004, and
incorporated herein by reference. |
|
|
|
|
|
4.16
|
|
|
|
Amendment No. 1 to Purchase Agreement, dated as of April 13, 2005,
by and between Zix Corporation and Omicron Master Trust (excluding
schedules and exhibits) in connection with a restructuring of the
$20 million convertible note financing in 2004. Filed as Exhibit
4.1 to Zix Corporations Current Report on Form 8-K, dated April
14, 2005, and incorporated herein by reference. |
|
|
|
|
|
4.17
|
|
|
|
Purchase Agreement, dated as of November 1, 2004, by and between
Zix Corporation and Amulet Limited (excluding schedules and
exhibits) in connection with a $20 million convertible note
financing in 2004. Filed as Exhibit 4.2 to Zix Corporations
Current Report on Form 8-K, dated November 4, 2004, and
incorporated herein by reference. |
|
|
|
|
|
4.18
|
|
|
|
Amendment No. 1 to Purchase Agreement, dated as of April 13, 2005,
by and between Zix Corporation and Amulet Limited (excluding
schedules and exhibits) in connection with a restructuring of the
$20 million convertible note financing in 2004. Filed as Exhibit
4.2 to Zix Corporations Current Report on Form 8-K, dated April
14, 2005, and incorporated herein by reference. |
34
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
10.1
|
|
|
|
1990 Stock Option Plan of Zix Corporation (Amended and Restated as
of September 1999). Filed as Exhibit 10.1 to Zix Corporations
Quarterly Report on Form 10-Q for the quarterly period ended
September 30, 1999, and incorporated herein by reference. |
|
|
|
|
|
10.2
|
|
|
|
1992 Stock Option Plan of Zix Corporation (Amended and Restated as
of August 2000). Filed as Exhibit 10.2 to Zix Corporations Annual
Report on Form 10-K for the year ended December 31, 2003, and
incorporated herein by reference. |
|
|
|
|
|
10.3
|
|
|
|
1995 Long-Term Incentive Plan of Zix Corporation (Amended and
Restated as of September 20, 2000). Filed as Exhibit 10.3 to Zix
Corporations Quarterly Report on Form 10-Q for the quarterly
period ended September 30, 2000, and incorporated herein by
reference. |
|
|
|
|
|
10.4
|
|
|
|
1996 Employee Stock Purchase Plan of Zix Corporation (Amended and
Restated as of July 1, 2000). Filed as Exhibit 10.2 to Zix
Corporations Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2000, and incorporated herein by reference. |
|
|
|
|
|
10.5
|
|
|
|
Zix Corporation 1999 Directors Stock Option Plan (Amended and
Restated as of August 1, 2002). Filed as Exhibit 10.1 to Zix
Corporations Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2002, and incorporated herein by reference. |
|
|
|
|
|
10.6
|
|
|
|
Zix Corporation 2001 Employee Stock Option Plan (Amended and
Restated as of June 7, 2007). Filed as Exhibit 10.6 to Zix
Corporations Report on Form 8-K, filed June 12, 2007, and
incorporated herein by reference. |
|
|
|
|
|
10.7
|
|
|
|
Zix Corporations 2001 Stock Option Plan (Amended and Restated as
of June 7, 2007). Filed as Exhibit 10.5 to Zix Corporations
Report on Form 8-K, filed June 12, 2007, and incorporated herein
by reference. |
|
|
|
|
|
10.8
|
|
|
|
Zix Corporations 2003 New Employee Stock Option Plan (Amended and
Restated as of June 7, 2007). Filed as Exhibit 10.4 to Zix
Corporations Report on Form 8-K, filed June 12, 2007, and
incorporated herein by reference. |
|
|
|
|
|
10.9
|
|
|
|
Zix Corporation 2004 Stock Option Plan (Amended and Restated as of
June 7, 2007). Filed as Exhibit 10.3 to Zix Corporations Report
on Form 8-K, filed June 12, 2007, and incorporated herein by
reference. |
|
|
|
|
|
10.10
|
|
|
|
Zix Corporation 2004 Stock Option Plan (Amended and Restated as of
May 25, 2005). Filed as Exhibit 10.1 to Zix Corporations
Registration Statement on Form S-8 (Registration No. 333-126576),
dated July 13, 2005, and incorporated herein by reference. |
|
|
|
|
|
10.11
|
|
|
|
Zix Corporation 2004 Directors Stock Option Plan, dated May 6,
2004. Filed as Exhibit 10.2 to Zix Corporations Quarterly Report
on Form 10-Q for the quarterly period ended March 31, 2004, and
incorporated herein by reference. |
|
|
|
|
|
10.12
|
|
|
|
Zix Corporation 2006 Directors Stock Option Plan (Amended and
Restated as of June 7, 2007) Filed as Exhibit 10.1 to Zix
Corporations Current Report on Form 8-K, filed June 12, 2007, and
incorporated herein by reference. |
|
|
|
|
|
10.13
|
|
|
|
Form of Stock Option Agreement (with no change in control
provision) for Zix Corporation Stock Option Plans. Filed as
Exhibit 10.2 to Zix Corporations Registration Statement on Form
S-8 (Registration No. 333-126576), dated July 13, 2005, and
incorporated herein by reference. |
|
|
|
|
|
10.14
|
|
|
|
Form of Stock Option Agreement (with change in control
provision) for Zix Corporation Stock Option Plans. Filed as
Exhibit 10.3 to Zix Corporations Registration Statement on Form
S-8 (Registration No. 333-126576), dated July 13, 2005, and
incorporated herein by reference. |
|
|
|
|
|
10.15
|
|
|
|
Form of Stock Option Agreement (with acceleration event
provision) for Zix Corporation Stock Option Plans and applicable
to option agreements held by the Companys chief executive officer
and direct reports. Filed as Exhibit 10.17 to Zix Corporations
Annual Report on Form 10-K for the year ended December 31, 2007,
and incorporated herein by reference. |
|
|
|
|
|
10.16
|
|
|
|
Zix Corporation 401(k) Retirement Plan. Filed as Exhibit 10.10 to
Zix Corporations Annual Report on Form 10-K for the year ended
December 31, 2003, and incorporated herein by reference. |
35
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
10.17
|
|
|
|
Adoption Agreement relating to Zix Corporation 401(k) Retirement
Plan. Filed as Exhibit 10.11 to Zix Corporations Annual Report on
Form 10-K for the year ended December 31, 2003, and incorporated
herein by reference. |
|
|
|
|
|
10.18
|
|
|
|
Stock Option Agreement, dated February 24, 2004, between Zix
Corporation and Richard D. Spurr, covering 650,000 shares at
$10.80 exercise price per share. Filed as Exhibit 10.15 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2003, and incorporated herein by reference. |
|
|
|
|
|
10.19
|
|
|
|
Stock Option Agreement, dated November 17, 2004, between Zix
Corporation and Richard D. Spurr, covering 350,000 shares at $6.00
exercise price per share. Filed as Exhibit 10.18 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2004, and incorporated herein by reference. |
|
|
|
|
|
10.20
|
|
|
|
Stock Option Agreement, dated March 23, 2005, between Zix
Corporation and Richard D. Spurr, covering 350,000 shares at $3.78
exercise price per share. Filed as Exhibit 10.2 to Zix
Corporations Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2005, and incorporated herein by reference. |
|
|
|
|
|
10.21
|
|
|
|
Stock Option Agreement, dated March 2, 2006, between Zix
Corporation and Richard D. Spurr, covering 350,000 shares at $4.00
exercise price per share. Filed as Exhibit 10.25 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2006, and incorporated herein by reference. |
|
|
|
|
|
10.22
|
|
|
|
Stock Option Agreement, dated December 18, 2006, between Zix
Corporation and Richard D. Spurr, covering 400,000 shares at $1.50
exercise price per share. Filed as Exhibit 10.24 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2007, and incorporated herein by reference. |
|
|
|
|
|
10.23
|
|
|
|
Stock Option Agreement, dated December 20, 2007, between Zix
Corporation and Richard D. Spurr, covering 400,000 shares at $4.87
exercise price per share. Filed as Exhibit 10.25 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2007, and incorporated herein by reference. |
|
|
|
|
|
10.24
|
|
|
|
Stock Option Agreement, dated December 23, 2008, between Zix
Corporation and Richard D. Spurr, covering 100,000 shares at $1.11
exercise price per share. Filed as Exhibit 10.24 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2008, and incorporated herein by reference. |
|
|
|
|
|
10.25
|
|
|
|
Stock Option Agreement between Zix Corporation and Susan K. Conner
covering 130,000 shares at $1.70 exercise price per share (grant
date October 16, 2008). Filed as Exhibit 10.1 to Zix Corporations
Form 10-Q for the quarter ended September 30, 2008, and
incorporated herein by reference. |
|
|
|
|
|
10.26
|
|
|
|
Form of Zix Corporation Outside Director Stock Option Agreement.
Filed as Exhibit 10.3 to Zix Corporations Quarterly Report on
Form 10-Q for the quarterly period ended June 30, 2004, and
incorporated herein by reference. |
|
|
|
|
|
10.27
|
|
|
|
Amended and Restated Severance Agreement, entered into as of
December 18, 2008, between Zix Corporation and Richard D. Spurr
(amended for I.R.C. 409A compliance purposes). Filed as Exhibit
10.27 to Zix Corporations Annual Report on Form 10-K for the year
ended December 31, 2008, and incorporated herein by reference. |
|
|
|
|
|
10.28
|
|
|
|
Amended and Restated Severance Agreement, entered into as of
December 30, 2008, between Zix Corporation and David J. Robertson
(amended for I.R.C. 409A compliance purposes). Filed as Exhibit
10.30 to Zix Corporations Annual Report on Form 10-K for the year
ended December 31, 2008, and incorporated herein by reference. |
|
|
|
|
|
10.29
|
|
|
|
Form of Amended and Restated Separation Pay Agreement between Zix
Corporation and certain executive officers (amended for I.R.C.
409A compliance purposes). Filed as Exhibit 10.31 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2008, and incorporated herein by reference. |
36
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
10.30
|
|
|
|
Form of Amended and Restated Severance Agreement between Zix
Corporation and certain executive officers (amended for I.R.C.
409A compliance purposes). Filed as Exhibit 10.32 to Zix
Corporations Annual Report on Form 10-K for the year ended
December 31, 2008, and incorporated herein by reference. |
|
10.31
|
|
|
|
Lease Agreement, dated December 29, 2003, between Zix Corporation and 7-Eleven, Inc.
(excluding exhibits) (relating to Zix Corporations Dallas, Texas
facilities). Filed as Exhibit 10.24 to Zix Corporations Annual Report on Form 10-K for the year ended December 31, 2003, and incorporated herein by reference.
|
|
10.32
|
|
|
|
Letter of Agreement dated September 12, 2006 between MITEM Corporation and Zix Corporation.
Filed as Exhibit 10.2 to Zix Corporations Quarterly Report on Form 10-Q for the period ended September 30, 2006, and incorporated herein by reference.
|
|
10.33
|
|
|
|
Separation Pay Agreement, entered into as of February 8, 2010, between Zix
Corporation and James F. Brashear. Filed as Exhibit 10.40 to Zix
Corporations Annual Report on Form 10-K dated December 31, 2009, and incorporated herein by reference. |
|
10.34
|
|
|
|
Form of Zix Corporation Outside Director Stock Option Agreement. Filed
as Exhibit 10.1 to Zix
Corporations Quarterly Report on Form 10-Q dated June 30, 2010, and incorporated herein by reference.
|
|
10.35
|
|
|
|
Form of Zix Corporation Employee Stock Option Agreement. Filed as Exhibit 10.2 to Zix
Corporations Quarterly Report on Form 10-Q dated June 30, 2010, and incorporated herein by reference.
|
|
10.36
|
|
|
|
Form of Outside Board of Directors Indemnification Agreement. Filed as Exhibit 10.1 to Zix
Corporations Current Report on Form 8-K dated December 20, 2010, and incorporated herein by reference.
|
|
21.1
|
|
|
|
Subsidiaries of Zix Corporation.
Filed as Exhibit 21.1 to Zix Corporations Annual Report on
Form 10-K dated December 31, 2009, and incorporated herein by reference.
|
|
23.1*
|
|
|
|
Consent of Independent Registered Public Accounting Firm (Whitley Penn LLP). |
|
31.1*
|
|
|
|
Certification of Richard D. Spurr, President and Chief Executive Officer of the Company,
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
31.2*
|
|
|
|
Certification of Richard D. Spurr, Principal Financial Officer of the Company, pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
32.1*
|
|
|
|
Certification of CEO and PFO pursuant to 18 U.S.C. Section 1350, as adopted,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
99.1
|
|
|
|
Order and Final Judgment, United States District Court, Cause No.
3-04-CV-1931-K, Northern District of Texas, Dallas Division (dated June 16, 2008). Filed as Exhibit 99.1 to the Zix Corporation
Current Report on Form 8-K, filed June 17, 2008, and incorporated herein by reference. |
|
|
|
* |
|
Filed herewith. |
|
|
|
Management contract or compensatory plan or arrangement. |
37
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Dallas, state of Texas, on March 10, 2011.
|
|
|
|
|
|
ZIX CORPORATION
|
|
|
By: |
/s/ MICHAEL W. ENGLISH
|
|
|
|
Michael W. English |
|
|
|
Principal Accounting Officer |
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the Registrant and in the capacities indicated
on March 10, 2011.
|
|
|
Signature |
|
Title |
|
|
|
/s/ RICHARD D. SPURR
|
|
Chairman, Chief Executive Officer, President and Director |
|
|
|
(Richard D. Spurr)
|
|
(Principal Executive Officer and
Principal Financial Officer) |
|
|
|
/s/ ROBERT C. HAUSMANN
|
|
Director |
|
|
|
(Robert C. Hausmann) |
|
|
|
|
|
/s/ JAMES S. MARSTON
|
|
Director |
|
|
|
(James S. Marston) |
|
|
|
|
|
/s/ MARIBESS L. MILLER
|
|
Director |
|
|
|
(Maribess L. Miller) |
|
|
|
|
|
/s/ ANTONIO R. SANCHEZ III
|
|
Director |
|
|
|
(Antonio R. Sanchez III) |
|
|
38
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders
Zix Corporation
We have audited the accompanying consolidated balance sheets of Zix Corporation and subsidiaries
(the Company), as of December 31, 2010 and 2009, and the related consolidated statements of
operations, changes in stockholders equity (deficit), and cash flows for each of the three years
in the period ended December 31, 2010. The Companys management is responsible for these financial
statements. Our responsibility is to express an opinion on these financial statements based on our
audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. Our
audits of the financial statements included examining, on a test basis, evidence supporting the
amounts and disclosures in the financial statements, assessing the accounting principles used and
significant estimates made by management, and evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of the Company, as of December 31, 2010 and 2009, and the
results of their operations and their cash flows for each of the three years in the period ended
December 31, 2010, in conformity with accounting principles generally accepted in the United States
of America.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), the Companys internal control over financial reporting as of December 31,
2010, based on criteria established in Internal ControlIntegrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 10,
2011 expressed an unqualified opinion.
/s/ WHITLEY PENN LLP
Dallas, Texas
March 10, 2011
F-2
ZIX CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
24,619,000 |
|
|
$ |
13,287,000 |
|
Marketable securities |
|
|
|
|
|
|
25,000 |
|
Receivables, net |
|
|
1,344,000 |
|
|
|
760,000 |
|
Prepaid and other current assets |
|
|
1,115,000 |
|
|
|
1,135,000 |
|
Deferred tax assets |
|
|
1,056,000 |
|
|
|
7,000 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
28,134,000 |
|
|
|
15,214,000 |
|
Property and equipment, net |
|
|
2,209,000 |
|
|
|
2,137,000 |
|
Goodwill |
|
|
2,161,000 |
|
|
|
2,161,000 |
|
Deferred tax assets |
|
|
34,304,000 |
|
|
|
63,000 |
|
Other assets |
|
|
44,000 |
|
|
|
173,000 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
66,852,000 |
|
|
$ |
19,748,000 |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT) |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
562,000 |
|
|
$ |
769,000 |
|
Accrued expenses |
|
|
2,282,000 |
|
|
|
3,124,000 |
|
Deferred revenue |
|
|
15,331,000 |
|
|
|
14,478,000 |
|
License subscription note payable |
|
|
137,000 |
|
|
|
126,000 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
18,312,000 |
|
|
|
18,497,000 |
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
Deferred revenue |
|
|
1,439,000 |
|
|
|
2,821,000 |
|
License subscription note payable |
|
|
49,000 |
|
|
|
186,000 |
|
Deferred rent |
|
|
165,000 |
|
|
|
233,000 |
|
|
|
|
|
|
|
|
Total long-term liabilities |
|
|
1,653,000 |
|
|
|
3,240,000 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
19,965,000 |
|
|
|
21,737,000 |
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 17) |
|
|
|
|
|
|
|
|
Stockholders equity (deficit): |
|
|
|
|
|
|
|
|
Preferred stock, $1 par value, 10,000,000 shares authorized;
none issued and outstanding |
|
|
|
|
|
|
|
|
Common stock, $0.01 par value, 175,000,000 shares authorized;
69,505,919 issued and 67,178,738 outstanding in 2010 and
66,053,772 issued and 63,726,591 outstanding in 2009 |
|
|
695,000 |
|
|
|
661,000 |
|
Additional paid-in capital |
|
|
344,981,000 |
|
|
|
337,352,000 |
|
Treasury stock, at cost; 2,327,181 common shares in 2010 and 2009 |
|
|
(11,507,000 |
) |
|
|
(11,507,000 |
) |
Accumulated deficit |
|
|
(287,282,000 |
) |
|
|
(328,495,000 |
) |
|
|
|
|
|
|
|
Total stockholders equity (deficit) |
|
|
46,887,000 |
|
|
|
(1,989,000 |
) |
|
|
|
|
|
|
|
Total liabilities and stockholders equity (deficit) |
|
$ |
66,852,000 |
|
|
$ |
19,748,000 |
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-3
ZIX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Revenues |
|
$ |
33,066,000 |
|
|
$ |
26,407,000 |
|
|
$ |
22,604,000 |
|
Cost of revenues |
|
|
6,468,000 |
|
|
|
4,576,000 |
|
|
|
4,105,000 |
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
26,598,000 |
|
|
|
21,831,000 |
|
|
|
18,499,000 |
|
Research and development expenses |
|
|
5,089,000 |
|
|
|
3,619,000 |
|
|
|
2,677,000 |
|
Selling, general and administrative expenses |
|
|
16,363,000 |
|
|
|
15,927,000 |
|
|
|
14,237,000 |
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
5,146,000 |
|
|
|
2,285,000 |
|
|
|
1,585,000 |
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
Investment and other income |
|
|
96,000 |
|
|
|
214,000 |
|
|
|
606,000 |
|
Interest expense |
|
|
(22,000 |
) |
|
|
(21,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income |
|
|
74,000 |
|
|
|
193,000 |
|
|
|
606,000 |
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes |
|
|
5,220,000 |
|
|
|
2,478,000 |
|
|
|
2,191,000 |
|
Income tax benefit (expense) |
|
|
35,500,000 |
|
|
|
(67,000 |
) |
|
|
(42,000 |
) |
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
40,720,000 |
|
|
$ |
2,411,000 |
|
|
$ |
2,149,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations before
income taxes |
|
|
762,000 |
|
|
|
(6,846,000 |
) |
|
|
(7,591,000 |
) |
Income tax expense |
|
|
(269,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations |
|
$ |
493,000 |
|
|
$ |
(6,846,000 |
) |
|
$ |
(7,591,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
41,213,000 |
|
|
$ |
(4,435,000 |
) |
|
$ |
(5,442,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations: |
|
$ |
0.63 |
|
|
$ |
0.04 |
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations: |
|
$ |
0.01 |
|
|
$ |
(0.11 |
) |
|
$ |
(0.12 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss): |
|
$ |
0.64 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations: |
|
$ |
0.61 |
|
|
$ |
0.04 |
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations: |
|
$ |
0.01 |
|
|
$ |
(0.11 |
) |
|
$ |
(0.11 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss): |
|
$ |
0.62 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.08 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Basic common shares outstanding |
|
|
64,401,384 |
|
|
|
63,422,088 |
|
|
|
62,981,958 |
|
|
|
|
|
|
|
|
|
|
|
Diluted common shares outstanding |
|
|
66,741,681 |
|
|
|
64,050,751 |
|
|
|
65,856,382 |
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-4
ZIX CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity (Deficit) |
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
Common Stock |
|
|
Paid-In |
|
|
Treasury |
|
|
Accumulated |
|
|
Stockholders |
|
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Stock |
|
|
Deficit |
|
|
Equity (Deficit) |
|
Balance, December 31, 2007 |
|
|
64,959,649 |
|
|
$ |
650,000 |
|
|
$ |
329,186,000 |
|
|
$ |
(11,507,000 |
) |
|
$ |
(318,618,000 |
) |
|
$ |
(289,000 |
) |
Issuance of common stock upon exercise
of stock options |
|
|
67,342 |
|
|
|
1,000 |
|
|
|
163,000 |
|
|
|
|
|
|
|
|
|
|
|
164,000 |
|
Shares issued to employees in lieu of
cash compensation |
|
|
619,672 |
|
|
|
5,000 |
|
|
|
1,692,000 |
|
|
|
|
|
|
|
|
|
|
|
1,697,000 |
|
Employee stock-based compensation costs |
|
|
|
|
|
|
|
|
|
|
2,498,000 |
|
|
|
|
|
|
|
|
|
|
|
2,498,000 |
|
Non-employee stock-based compensation |
|
|
|
|
|
|
|
|
|
|
48,000 |
|
|
|
|
|
|
|
|
|
|
|
48,000 |
|
Other |
|
|
|
|
|
|
|
|
|
|
21,000 |
|
|
|
|
|
|
|
|
|
|
|
21,000 |
|
Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,442,000 |
) |
|
|
(5,442,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008 |
|
|
65,646,663 |
|
|
|
656,000 |
|
|
|
333,608,000 |
|
|
|
(11,507,000 |
) |
|
|
(324,060,000 |
) |
|
|
(1,303,000 |
) |
Issuance of common stock upon exercise
of stock options |
|
|
11,743 |
|
|
|
1,000 |
|
|
|
18,000 |
|
|
|
|
|
|
|
|
|
|
|
19,000 |
|
Issuance of common stock upon exercise
of warrants |
|
|
395,366 |
|
|
|
4,000 |
|
|
|
632,000 |
|
|
|
|
|
|
|
|
|
|
|
636,000 |
|
Employee stock-based compensation costs |
|
|
|
|
|
|
|
|
|
|
3,063,000 |
|
|
|
|
|
|
|
|
|
|
|
3,063,000 |
|
Non-employee stock-based compensation |
|
|
|
|
|
|
|
|
|
|
31,000 |
|
|
|
|
|
|
|
|
|
|
|
31,000 |
|
Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,435,000 |
) |
|
|
(4,435,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009 |
|
|
66,053,772 |
|
|
|
661,000 |
|
|
|
337,352,000 |
|
|
|
(11,507,000 |
) |
|
|
(328,495,000 |
) |
|
|
(1,989,000 |
) |
Issuance of common stock upon exercise
of stock options |
|
|
1,537,147 |
|
|
|
15,000 |
|
|
|
2,771,000 |
|
|
|
|
|
|
|
|
|
|
|
2,786,000 |
|
Issuance of common stock upon exercise
of warrants |
|
|
1,915,000 |
|
|
|
19,000 |
|
|
|
2,930,000 |
|
|
|
|
|
|
|
|
|
|
|
2,949,000 |
|
Employee stock-based compensation costs |
|
|
|
|
|
|
|
|
|
|
1,886,000 |
|
|
|
|
|
|
|
|
|
|
|
1,886,000 |
|
Non-employee stock-based compensation |
|
|
|
|
|
|
|
|
|
|
42,000 |
|
|
|
|
|
|
|
|
|
|
|
42,000 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,213,000 |
|
|
|
41,213,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2010 |
|
|
69,505,919 |
|
|
$ |
695,000 |
|
|
$ |
344,981,000 |
|
|
$ |
(11,507,000 |
) |
|
$ |
(287,282,000 |
) |
|
$ |
46,887,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-5
ZIX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
41,213,000 |
|
|
$ |
(4,435,000 |
) |
|
$ |
(5,442,000 |
) |
Non-cash items in net income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
1,402,000 |
|
|
|
1,328,000 |
|
|
|
1,268,000 |
|
Common stock issued to employees and non-employees
in lieu of cash |
|
|
|
|
|
|
|
|
|
|
1,181,000 |
|
Employee stock based compensation expense |
|
|
1,886,000 |
|
|
|
3,063,000 |
|
|
|
2,498,000 |
|
Non-employee stock-based compensation |
|
|
42,000 |
|
|
|
31,000 |
|
|
|
48,000 |
|
Changes in deferred taxes |
|
|
(35,290,000 |
) |
|
|
4,000 |
|
|
|
3,000 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Receivables |
|
|
(584,000 |
) |
|
|
(284,000 |
) |
|
|
643,000 |
|
Prepaid and other assets |
|
|
150,000 |
|
|
|
220,000 |
|
|
|
416,000 |
|
Accounts payable |
|
|
(190,000 |
) |
|
|
168,000 |
|
|
|
296,000 |
|
Deferred revenue |
|
|
(529,000 |
) |
|
|
(145,000 |
) |
|
|
1,341,000 |
|
Accrued and other liabilities |
|
|
(910,000 |
) |
|
|
653,000 |
|
|
|
(188,000 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
7,190,000 |
|
|
|
603,000 |
|
|
|
2,064,000 |
|
Investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(1,492,000 |
) |
|
|
(1,141,000 |
) |
|
|
(1,238,000 |
) |
Sales (purchases) of marketable securities |
|
|
25,000 |
|
|
|
(25,000 |
) |
|
|
1,734,000 |
|
Restricted cash investments, net |
|
|
|
|
|
|
28,000 |
|
|
|
(3,000 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
(1,467,000 |
) |
|
|
(1,138,000 |
) |
|
|
493,000 |
|
Financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
2,786,000 |
|
|
|
19,000 |
|
|
|
164,000 |
|
Proceeds from exercise of warrants |
|
|
2,949,000 |
|
|
|
636,000 |
|
|
|
|
|
Payment of license subscription note payable |
|
|
(126,000 |
) |
|
|
(78,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
5,609,000 |
|
|
|
577,000 |
|
|
|
164,000 |
|
|
|
|
|
|
|
|
|
|
|
Increase in cash and cash equivalents |
|
|
11,332,000 |
|
|
|
42,000 |
|
|
|
2,721,000 |
|
Cash and cash equivalents, beginning of year |
|
|
13,287,000 |
|
|
|
13,245,000 |
|
|
|
10,524,000 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year |
|
$ |
24,619,000 |
|
|
$ |
13,287,000 |
|
|
$ |
13,245,000 |
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-6
ZIX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Company Overview
Zix Corporation (ZixCorp, the Company, we, our, us) provides secure, Internet-based
email encryption applications in a SaaS model. These applications connect, protect and deliver
information in a secure manner, enabling the use of the Internet for applications requiring a high
level of security in the healthcare, finance, insurance and government sectors.
In 2009 we announced the planned exit of our e-Prescribing business to be completed by
December 31, 2010. The wind down of this business was completed on schedule and the Company
successfully exited this business on December 31, 2010. The e-Prescribing business has been
reclassified as a discontinued operation on a retrospective basis in the Companys Statements of
Operations included in this Form 10-K. There were no significant assets or liabilities related to
the discontinued operations at December 31, 2010.
2. Summary of Significant Accounting Policies
Basis of Presentation The accompanying consolidated financial statements include the
accounts of all our wholly-owned subsidiaries and are prepared in accordance with accounting
principles generally accepted in the United States of America. All inter-company accounts and
transactions have been eliminated in consolidation.
Use of Estimates The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America requires management to
make estimates and assumptions that affect the reported amount of assets and disclosure of
contingent assets and liabilities at the date of the consolidated financial statements and the
reported amounts of revenue and expenses during the reported period. Our significant estimates
include primarily those required in the valuation of impairment analysis of goodwill, property and
equipment, revenue recognition, allowances for doubtful accounts, stock-based compensation,
litigation accruals, valuation allowances for deferred tax assets and tax accruals. Although we
believe that adequate accruals have been made for unsettled issues, additional gains or losses
could occur in future years from resolutions of outstanding matters. Actual results could differ
materially from original estimates.
Cash Equivalents Cash investments with maturities of three months or less when purchased
are considered cash equivalents.
Fair Value of Financial Instruments The Company does not measure the fair value of any
financial instrument other than cash equivalents, options and warrants. The carrying values of
other financial instruments (receivables and accounts payable) are not recorded at fair value but
approximate fair values primarily due to their short-term nature. The carrying values of other
current assets and accrued expenses are also not recorded at fair value, but approximate fair
values primarily due to their short-term nature.
Valuation of Property and Equipment The accounting policies and estimates relating to
property and equipment are considered significant because of the potential impact that impairment,
obsolescence, or change in an assets useful life could have on the Companys operating results.
We record an impairment charge on the assets to be held and used when we determine based upon
certain triggering events that the carrying value of property and equipment may not be recoverable
based on expected undiscounted cash flows attributable to such assets. The amount of a potential
impairment is determined by comparing the carrying amount of the asset to either the value
determined from a projected discounted cash flow method, using a discount rate that is considered
to be commensurate with the risk inherent in the Companys current business model or the estimated
fair market value. Assumptions are made with respect to future net cash flows expected to be
generated by the related asset. An impairment charge would be recorded for an amount by which the
carrying value of the asset exceeded the discounted projected net cash flows or estimated fair
market value. Also, even where a current impairment charge is not necessary, the remaining useful
lives are evaluated. No impairment was recorded for any of the periods presented.
F-7
Property and equipment are recorded at cost and depreciated or amortized using the
straight-line method over their estimated useful lives as follows: computer and office equipment
and software three years; leasehold improvements the shorter of five years or the lease term;
and furniture and fixtures five years.
Goodwill We account for the valuation of goodwill and other intangible assets after
classifying intangible assets into three categories: (1) intangible assets with finite lives
subject to amortization; (2) intangible assets with indefinite lives not subject to amortization;
and (3) goodwill. For intangible assets with finite lives, tests for impairment must be performed
if conditions exist that indicate the carrying value may not be recoverable. For intangible assets
with indefinite lives and goodwill, tests for impairment must be performed at least annually or
more frequently if events or circumstances indicate that assets might be impaired.
Goodwill was $2,161,000, or 3% of total assets at December 31, 2010; and was $2,161,000, or
11% of total assets at December 31, 2009.
Our goodwill is not being amortized, but we do evaluate the goodwill for impairment annually
in the fourth quarter, or when there is reason to believe that the value has been diminished or
impaired. Evaluations for possible impairment are based upon a comparison of the estimated fair
value of the reporting unit to which the goodwill has been assigned to, versus the sum of the
carrying value of the assets and liabilities of that unit including the assigned goodwill value.
The fair values used in this evaluation are estimated based on the Companys market capitalization,
which is based on the outstanding stock and market price of the stock. Impairment is deemed to
exist if the net book value of the unit exceeds its estimated fair value. No impairment was
recorded for any of the periods presented.
Deferred Tax Assets Deferred tax assets are recognized if it is more likely than not that
the benefit of the deferred tax asset will be realized on future federal income tax returns. At
December 31, 2010, we provided a valuation allowance against a significant portion of our
accumulated U.S. deferred tax assets of $75,352,000, reflecting our historical losses and the
uncertainty of future taxable income sufficient to utilize net operating loss carryforwards prior
to their expiration. Our total deferred tax asset not subject to a valuation allowance is valued at
$35,360,000, and consists of $35,300,000 for net operation loss carryforwards and $48,000 for U.S.
state income tax credits and $12,000 for a Canadian deferred tax asset relating to temporary timing
differences between GAAP and tax-related expense. If U.S. taxable income increases from its current
level in a future period or if the facts and circumstances on which our estimates and assumptions
are based were to change, thereby impacting the likelihood of realizing the deferred tax assets,
judgment would have to be applied in determining the amount of valuation allowance no longer
required. Reversal of all or a part of this valuation allowance could have a significant positive
impact on operating results in the period that it becomes more likely than not that certain of the
Companys deferred tax assets will be realized.
Leases A leased asset whose lease terms meet the criteria for capitalization is recorded as
an asset and depreciated. If a lease does not meet the criteria for capitalization, it is
classified as an operating lease and payments are recorded as rent expense. For 2010 and 2009 we
had no leases that qualified as capital leases. Lease renewal options which we are reasonably
assured of using and the related payments are taken into account when initially classifying and
recording the lease as a capital lease obligation or as straight-line rent if an operating lease.
We have no renewal options which are reasonably assured of exercising as of December 31, 2010.
Funds provided by the lessor for leasehold improvements are recorded as a deferred lease incentive
and amortized as a reduction of rent expense over the lease term.
Revenue Recognition We develop, market, and support applications that connect, protect and
deliver information in a secure manner. Our services can be placed into several key revenue
categories where each category has similar revenue recognition traits: Email Encryption
subscription-based services, various transaction fees and related professional services. The
majority of the revenues generated are through a combination of direct sales and a network of
resellers and other distribution partners.
Under all product categories and distribution models, we recognize revenue after all of the
following occur:
|
|
|
persuasive evidence of an arrangement exists,
|
F-8
|
|
|
delivery has occurred or services have been rendered, |
|
|
|
|
the price is fixed and determinable, and |
|
|
|
|
collectability is reasonably assured. |
When we are engaged in a complex product deployment, customer acceptance may have to occur
before the transaction is considered complete. In this situation, no revenue is recognized until
the customer accepts the product. Discounts provided to customers are recorded as reductions in
revenue.
Our email encryption service is a subscription service. Providing this service includes
delivering subscribed-for software and providing secure electronic communications and customer
support throughout the subscription period. Our email subscribers generally execute multiple-year
contracts that are irrevocable and non-refundable in nature and require annual, up-front payments.
Subscription fees received from customers are initially recorded as deferred revenue and then
recognized as revenue ratably over the subscription period. We do not offer stand alone services.
Further, our services primarily include manufacturer provided warranty provisions. We recorded no
warranty expense in any of the presented periods.
The discontinued e-Prescribing service was also a subscription service. Some of these
services incorporated transaction fees per event occurrence or when predetermined usage levels had
been reached. These transaction fees were recognized as revenue when the transaction occurred or
when a predetermined usage level had been achieved, and when the amounts were fixed and
determinable.
Software Development Costs Costs incurred in the development and testing of software used
in the Companys Email Encryption and e-Prescribing Services related to research, project planning,
training, maintenance and general and administrative activities, and overhead costs are expensed as
incurred. The costs of relatively minor upgrades and enhancements to the software are also expensed
as incurred.
Costs for the development of new software solutions and substantial enhancements to existing
software solutions are expensed as incurred until technological feasibility has been established,
at which time any additional costs would be capitalized. No research and development costs have
been capitalized because we believe that technological feasibility is established concurrent with
general release to customers.
Advertising
Expense Advertising costs are expensed as incurred. Our
continuing operations include advertising expense of $361,000,
$278,000 and $305,000 in 2010, 2009 and 2008, respectively.
Stock Based Compensation We currently use the straight-line amortization method for
recognizing stock option compensation costs. For periods prior to January 1, 2006, we used the
intrinsic value method to account for stock-based compensation plans. Our share-based awards are
limited to stock options.
The measurement and recognition of compensation expense for all share-based payment awards
made to our employees, directors or outside service providers are based on the estimated fair value
of the awards on the grant dates. The grant date fair value is estimated using either an
option-pricing model which is consistent with the terms of the award or a market observed price, if
such a price exists. Such cost is recognized over the period during which an employee, director or
outside service provider is required to provide service in exchange for the award, i.e., the
requisite service period (which is usually the vesting period). We also estimate the number of
instruments that will ultimately be earned, rather than accounting for forfeitures as they occur.
Earnings Per Share (EPS) Basic EPS is based on the weighted average number of common
shares outstanding during each period. Diluted EPS adjusts Basic EPS for the effects of dilutive
common stock equivalents outstanding during each period using the treasury stock method.
New Accounting Standards
Revenue Recognition
F-9
In October 2009, the Financial Accounting Standards Board (FASB) issued guidance on
revenue recognition that becomes effective January 1, 2011, with earlier adoption permitted. Under
the new guidance tangible products that have software components that are essential to the
functionality of the tangible product will no longer be within the scope of the software revenue
recognition guidance; such software-enabled products will now be subject to other relevant revenue
recognition guidance. Additionally, the FASB issued authoritative guidance on revenue arrangements
with multiple deliverables that are outside the scope of the software revenue recognition guidance.
Under the new guidance, when VSOE or third party evidence for deliverables in an arrangement cannot
be determined, a best estimate of the selling price is required to separate deliverables and
allocate arrangement consideration using the relative selling price method. The new guidance
includes new disclosure requirements on how the application of the relative selling price method
affects the timing and amount of revenue recognition. We do not anticipate that this new guidance
will have a material impact on our consolidated financial statements.
3. Discontinued Operations
On December 31, 2010, Zix Corporation completed the previously announced (see Current Report
filed on Form 8-K/A dated January 6, 2010) wind down of its e-Prescribing business, and discontinued
operating this line of business. After completing a full strategic review of the e-Prescribing
business and exploring its viability and contribution to increasing shareholder value, the Board of
Directors and management determined the decision to exit the e-Prescribing business was in the best
interests of the Company and its shareholders and will allow increased resources and focus to be
committed to its larger segment- Email Encryption.
The wind down of the business entailed the fulfillment of existing contracts. Assets used by
this segment, primarily business computer servers, were compatible with the remaining business,
Email Encryption, and were therefore absorbed by that business. As a result, no gain or loss on
disposal of assets was incurred. Prior to the completion of the wind down, this business line had
been a reportable segment. The following table summarizes the components of the Income (loss) from
discontinued operations presented in our Statement of Operations for 2010, 2009 and 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Revenues |
|
$ |
2,632,000 |
|
|
$ |
4,244,000 |
|
|
$ |
5,431,000 |
|
Cost of revenues |
|
|
1,266,000 |
|
|
|
4,808,000 |
|
|
|
5,745,000 |
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
1,366,000 |
|
|
|
(564,000 |
) |
|
|
(314,000 |
) |
Research and development expenses |
|
|
300,000 |
|
|
|
3,329,000 |
|
|
|
3,481,000 |
|
Selling, general and administrative expenses |
|
|
304,000 |
|
|
|
2,953,000 |
|
|
|
3,796,000 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
762,000 |
|
|
$ |
(6,846,000 |
) |
|
$ |
(7,591,000 |
) |
|
|
|
|
|
|
|
|
|
|
Our
discontinued operations includes depreciation and amortization
expense related to property and equipment of $121,000, $311,000 and
$371,000 in 2010, 2009 and 2008, respectively.
During 2010 we reduced the costs of operating this business and transferred shared resources
to the remaining business while meeting the requirements of our existing contracts. We also
discontinued our recruiting efforts for the new e-Prescribing deployments and reduced the
associated recruitment and deployment expenses. Additionally, customers requesting to renew
existing contracts set to expire during 2010 were renewed to terminate no later than December 31,
2010. These actions resulted in significantly lower costs and lower revenue in 2010 compared to
2009 and 2008.
4. Stock Options and Stock-based Employee Compensation
Below is a summary of common stock options outstanding at December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized |
|
|
Options |
|
|
Options |
|
|
Available |
|
|
|
Shares |
|
|
Outstanding |
|
|
Vested |
|
|
for Grant |
|
Employee and Director Stock Option Plans: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1992 Stock Option Plan |
|
|
450,000 |
|
|
|
12,833 |
|
|
|
12,833 |
|
|
|
|
|
1995 Long-term Incentive Plan |
|
|
1,825,000 |
|
|
|
859,000 |
|
|
|
859,000 |
|
|
|
|
|
1999 Directors Stock Option Plan |
|
|
975,000 |
|
|
|
237,091 |
|
|
|
237,091 |
|
|
|
|
|
2001 Stock Option Plan |
|
|
2,525,000 |
|
|
|
1,416,391 |
|
|
|
1,392,104 |
|
|
|
315,667 |
|
2001 Employee Stock Option Plan |
|
|
300,000 |
|
|
|
180,055 |
|
|
|
173,016 |
|
|
|
55,544 |
|
2003 New Employee Stock Option Plan |
|
|
500,000 |
|
|
|
246,870 |
|
|
|
168,369 |
|
|
|
135,074 |
|
2004 Stock Option Plan |
|
|
5,000,000 |
|
|
|
3,069,226 |
|
|
|
2,721,853 |
|
|
|
959,280 |
|
F-10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized |
|
|
Options |
|
|
Options |
|
|
Available |
|
|
|
Shares |
|
|
Outstanding |
|
|
Vested |
|
|
for Grant |
|
2004 Directors Stock Option Plan |
|
|
300,000 |
|
|
|
185,000 |
|
|
|
185,000 |
|
|
|
|
|
2006 Directors Stock Option Plan |
|
|
1,100,000 |
|
|
|
665,426 |
|
|
|
510,090 |
|
|
|
242,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total employee and director stock option plans |
|
|
12,975,000 |
|
|
|
6,871,892 |
|
|
|
6,259,356 |
|
|
|
1,707,588 |
|
Executive Stock Option Agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard D. Spurr, Chairman, President and CEO |
|
|
650,000 |
|
|
|
650,000 |
|
|
|
650,000 |
|
|
|
|
|
Other executive stock option agreements |
|
|
450,000 |
|
|
|
125,000 |
|
|
|
125,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total executive stock option agreements |
|
|
1,100,000 |
|
|
|
775,000 |
|
|
|
775,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
14,075,000 |
|
|
|
7,646,892 |
|
|
|
7,034,356 |
|
|
|
1,707,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Under all of our stock option plans, new shares are issued when options are exercised.
Employee and Director Stock Option Plans
We have non-qualified stock options outstanding to employees, directors, and third parties
under various stock option plans. The plans require the exercise price of options granted under
these plans to equal or exceed the fair market value of the Companys common stock on the date of
grant. The options, subject to termination of employment, generally expire ten years from the date
of grant. Employee options generally vest pro-rata and quarterly over three years. Option grants to
employees, officers and directors frequently contain accelerated vesting provisions upon the
occurrence of a change of control, as defined in the applicable option agreements.
Executive Stock Option Agreements:
Richard D. Spurr In January 2004, Mr. Richard D. Spurr was appointed president and chief
operating officer of the Company. Mr. Spurr received non-shareholder approved options to acquire
650,000 shares of ZixCorp common stock at an exercise price of $10.80 per share. These options
vested 25% in April 2004 and the remaining balance vested ratably on a quarterly basis through
January 2007. At December 31, 2010, all 650,000 options were still outstanding. Mr. Spurr was
appointed Chief Executive Officer in March 2005, and Chairman of the Board in February 2006.
Other Executive Stock Option Agreements In 2001 and 2002, non-shareholder approved options
to purchase 450,000 shares of common stock were granted to key Company executives, which became
fully vested in March 2005. At December 31, 2010, 125,000 of these options remain outstanding with
an exercise price of $5.25 per share.
Other Stock Option Agreements:
From time to time we may grant stock options to consultants, contractors and other third
parties for services provided to the Company. These options are expensed based on their fair values
as calculated by using the Black-Scholes Option Pricing Model (BSOPM). At December 31, 2010,
options outstanding to non-employees were 255,000, which were granted from employee stock option
plans.
Accounting Treatment
On January 1, 2006, we adopted on a prospective basis the straight-line amortization method
for recognizing stock option compensation costs. For periods prior to January 1, 2006, we used the
intrinsic value method to account for stock-based compensation plans. Our share-based awards are
limited to stock options.
For the twelve months ended December 31, 2010, 2009 and 2008, respectively, the total
stock-based compensation expense was recorded to the following line items of our consolidated
statement of operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Cost of revenues |
|
$ |
161,000 |
|
|
$ |
132,000 |
|
|
$ |
86,000 |
|
Research and development expenses |
|
|
183,000 |
|
|
|
169,000 |
|
|
|
108,000 |
|
Selling, general and administrative expenses |
|
|
1,449,000 |
|
|
|
2,006,000 |
|
|
|
1,626,000 |
|
Discontinued operations |
|
|
93,000 |
|
|
|
756,000 |
|
|
|
678,000 |
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
$ |
1,886,000 |
|
|
$ |
3,063,000 |
|
|
$ |
2,498,000 |
|
|
|
|
|
|
|
|
|
|
|
F-11
There were 1,537,147 stock options exercised for the twelve months ended December 31, 2010. As
a result of these stock option exercises, there was $209,000 excess tax benefits recorded in 2010.
For the comparative period in 2009, there were 11,743 stock option exercises and $1,000 excess tax
benefits recorded. A deferred tax asset totaling $595,000 and $967,000 resulting from stock-based
compensation expenses was recorded for the twelve months ended December 31, 2010 and 2009,
respectively.
As of December 31, 2010, there was $654,000 of total unrecognized stock-based compensation
related to non-vested share-based compensation awards granted under the stock option plans. This
cost is expected to be recognized over a weighted average period of 0.9 years.
During the third quarter of 2009, the Company converted to a new third party stock option
system. Although both the new and the legacy systems record the same expense over the life of fully
vested stock options, the timing difference created by the two different systems required that we
align the two systems upon conversion. In the third quarter of 2009 our stock compensation expense
includes a non-recurring, non-cash true-up of $482,000 in stock-based compensation expense which
was the amount of the forfeiture expense related to vesting options previously deferred in the
legacy system most of which was included in SG&A expenses.
We used the BSOPM to determine the fair value of option grants made during 2010, 2009 and
2008. On January 1, 2006, we elected to use the simplified method to calculate the estimated life
of options granted to employees. The use of the simplified method has been extended until such
time when we have sufficient information to make more refined estimates on the estimated life of
our options. The expected stock price volatility was calculated by averaging the historical
volatility of the Companys common stock over a term equal to the expected life of the options.
The following weighted average assumptions were applied in determining the fair value of
options granted during the respective periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Risk-free interest rate |
|
|
2.79 |
% |
|
|
2.20 |
% |
|
|
2.57 |
% |
Expected option life (years) |
|
|
5.8 |
|
|
|
5.7 |
|
|
|
5.8 |
|
Expected stock price volatility |
|
|
79 |
% |
|
|
79 |
% |
|
|
78 |
% |
Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of options granted |
|
$ |
1.36 |
|
|
$ |
0.84 |
|
|
$ |
1.71 |
|
The assumptions used in the BSOPM valuation are critical as a change in any given factor could
have a material impact on the financial results of the Company.
Stock Option Activity
The following is a summary of all stock option transactions for the three years ended December
31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
Weighted |
|
|
Average |
|
|
|
|
|
|
|
Average |
|
|
Remaining |
|
|
|
|
|
|
|
Exercise |
|
|
Contractual |
|
|
|
Shares |
|
|
Price |
|
|
Term (Yrs) |
|
Outstanding at January 1, 2008 |
|
|
9,538,713 |
|
|
$ |
5.16 |
|
|
|
|
|
Granted at market price |
|
|
923,220 |
|
|
$ |
2.54 |
|
|
|
|
|
Cancelled or expired |
|
|
(355,224 |
) |
|
$ |
10.16 |
|
|
|
|
|
Exercised |
|
|
(67,342 |
) |
|
$ |
2.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
10,039,367 |
|
|
$ |
4.76 |
|
|
|
|
|
Granted at market price |
|
|
196,684 |
|
|
$ |
1.49 |
|
|
|
|
|
Cancelled or expired |
|
|
(653,196 |
) |
|
$ |
9.15 |
|
|
|
|
|
Exercised |
|
|
(11,743 |
) |
|
$ |
1.55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2009 |
|
|
9,571,112 |
|
|
$ |
4.40 |
|
|
|
|
|
Granted at market price |
|
|
724,072 |
|
|
$ |
1.98 |
|
|
|
|
|
Cancelled or expired |
|
|
(1,111,145 |
) |
|
$ |
6.29 |
|
|
|
|
|
Exercised |
|
|
(1,537,147 |
) |
|
$ |
1.82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2010 |
|
|
7,646,892 |
|
|
$ |
4.42 |
|
|
|
5.04 |
|
|
|
|
|
|
|
|
|
|
|
Options exercisable at December 31, 2010 |
|
|
7,034,356 |
|
|
$ |
4.64 |
|
|
|
4.72 |
|
|
|
|
|
|
|
|
|
|
|
F-12
At December 31, 2010, we had 3,907,804 options outstanding and 3,305,267 options exercisable
in which the exercise price was lower than the market value of the Companys common stock. The
aggregate intrinsic value of these options was $7,008,686 and $5,549,644, respectively. At
December 31, 2009, we had 2,341,177 options outstanding and 1,937,308 options exercisable in which
the exercise price was lower than the market value of the Companys common stock. The aggregate
intrinsic value of these options was $654,237 and $499,656, respectively.
The total intrinsic value of options exercised during the years ended December 31, 2010 and
2009, was $2,209,000 and $8,000, respectively.
Summarized information about stock options outstanding at December 31, 2010, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
Options Exercisable |
|
|
|
|
|
|
|
Weighted Average |
|
|
Weighted |
|
|
|
|
|
|
Weighted |
|
Range of |
|
Number |
|
|
Remaining |
|
|
Average |
|
|
Number |
|
|
Average |
|
Exercise Prices |
|
Outstanding |
|
|
Contractual Life |
|
|
Exercise Price |
|
|
Exercisable |
|
|
Exercise Price |
|
$1.11 $1.99 |
|
|
1,709,358 |
|
|
|
5.90 |
|
|
$ |
1.53 |
|
|
|
1,408,280 |
|
|
$ |
1.53 |
|
$2.00 $3.49 |
|
|
1,200,648 |
|
|
|
5.96 |
|
|
$ |
2.60 |
|
|
|
904,389 |
|
|
$ |
2.77 |
|
$3.50 $4.99 |
|
|
2,738,262 |
|
|
|
4.71 |
|
|
$ |
4.43 |
|
|
|
2,723,063 |
|
|
$ |
4.43 |
|
$5.00 $5.99 |
|
|
515,927 |
|
|
|
2.75 |
|
|
$ |
5.09 |
|
|
|
515,927 |
|
|
$ |
5.09 |
|
$6.00 $8.99 |
|
|
620,816 |
|
|
|
3.06 |
|
|
$ |
6.53 |
|
|
|
620,816 |
|
|
$ |
6.53 |
|
$9.00 $13.00 |
|
|
861,881 |
|
|
|
2.94 |
|
|
$ |
10.68 |
|
|
|
861,881 |
|
|
$ |
10.68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,646,892 |
|
|
|
5.04 |
|
|
$ |
4.42 |
|
|
|
7,034,356 |
|
|
$ |
4.64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
There were 8,620,793 and 7,613,724 exercisable options at December 31, 2009 and 2008,
respectively.
Reserved Common Stock
At December 31, 2010, we held no shares of common stock in reserve for potential future grants
in lieu of cash compensation to employees.
Common Stock Issued in Lieu of Cash
For the year ended December 31, 2008, we paid certain employee sales commissions and other
incentive bonuses in Company stock in lieu of cash under a program established for this purpose in
2003. During 2008 we issued 619,672 shares of common stock under this program at a weighted
average fair value of $2.74 per share. We valued this stock at the fair value on the date of
issuance. For the years ended December 31, 2010 and 2009, there were no unrestricted shares of
common stock issued under the program. For 2008 common stock issued to employees for compensation
in lieu of cash was $1,697,000.
5. Supplemental Cash Flow Information
Supplemental information relating to interest, taxes, and noncash activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Cash interest paid |
|
$ |
22,000 |
|
|
$ |
21,000 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
Income tax payments |
|
$ |
262,000 |
|
|
$ |
196,000 |
|
|
$ |
53,000 |
|
|
|
|
|
|
|
|
|
|
|
Payables related to purchases of capitalized assets |
|
$ |
17,000 |
|
|
$ |
89,000 |
|
|
$ |
51,000 |
|
|
|
|
|
|
|
|
|
|
|
Assets sold to customers as part of their subscription service |
|
$ |
9,000 |
|
|
$ |
2,000 |
|
|
$ |
16,000 |
|
|
|
|
|
|
|
|
|
|
|
Issuance of promissory note for software license service agreement |
|
$ |
|
|
|
$ |
390,000 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued in lieu of accrued expenses (see Note 4) |
|
$ |
|
|
|
$ |
|
|
|
$ |
516,000 |
|
|
|
|
|
|
|
|
|
|
|
Accrued expenses relating to private placement common stock |
|
$ |
|
|
|
$ |
|
|
|
$ |
20,000 |
|
|
|
|
|
|
|
|
|
|
|
F-13
6. Receivables, net
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
Receivables |
|
$ |
1,376,000 |
|
|
$ |
786,000 |
|
Allowance for returns and doubtful accounts |
|
|
(32,000 |
) |
|
|
(26,000 |
) |
Note receivable |
|
|
476,000 |
|
|
|
484,000 |
|
Allowance for note receivable |
|
|
(476,000 |
) |
|
|
(484,000 |
) |
|
|
|
|
|
|
|
Receivables, net |
|
$ |
1,344,000 |
|
|
$ |
760,000 |
|
|
|
|
|
|
|
|
The allowance for doubtful accounts includes all specific accounts receivable which we believe
are likely not collectable based on known information. In addition, we record 2.5% of all accounts
receivable greater than 90 days past due, net of those accounts specifically reserved, as a general
allowance against accounts that could potentially become uncollectible.
The note receivable represents the remaining outstanding balance of an original note related
to the sale of a product line in 2005 in the amount of $540,000. This was fully reserved at the
time of the sale as the notes collectability was not assured. The note receivable is fully
reserved at December 31, 2010.
7. Prepaid and other current assets
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
Inventory |
|
$ |
|
|
|
$ |
8,000 |
|
Deferred cost of sales charges |
|
|
|
|
|
|
97,000 |
|
Prepaid insurance, maintenance, software licenses and other |
|
|
1,046,000 |
|
|
|
1,029,000 |
|
|
|
|
|
|
|
|
Tax-related |
|
|
69,000 |
|
|
|
1,000 |
|
|
|
|
|
|
|
|
Prepaid and other current assets |
|
$ |
1,115,000 |
|
|
$ |
1,135,000 |
|
|
|
|
|
|
|
|
Inventory and deferred cost of sales assets in 2009 related to our discontinued e-Prescribing
operations (see Note 3).
8. Property and Equipment
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
Computer and office equipment and software |
|
$ |
24,173,000 |
|
|
$ |
23,711,000 |
|
Leasehold improvements |
|
|
4,899,000 |
|
|
|
4,876,000 |
|
Furniture and fixtures |
|
|
1,366,000 |
|
|
|
1,220,000 |
|
|
|
|
|
|
|
|
|
|
|
30,438,000 |
|
|
|
29,807,000 |
|
Less accumulated depreciation and amortization |
|
|
(28,229,000 |
) |
|
|
(27,670,000 |
) |
|
|
|
|
|
|
|
|
|
$ |
2,209,000 |
|
|
$ |
2,137,000 |
|
|
|
|
|
|
|
|
Our
continuing operations includes depreciation and amortization expense related to property and equipment
of $1,281,000, $1,017,000, and $897,000 in 2010, 2009, and 2008, respectfully.
9. Goodwill
At December 31, 2010 and 2009, we had goodwill totaling $2,161,000. We evaluate goodwill for
impairment annually in the fourth quarter, or when there is reason to believe that the value has
been diminished or impaired. There were no impairment indicators to the goodwill recorded as of
December 31, 2010.
10. Accrued Expenses
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
Employee compensation and benefits |
|
$ |
818,000 |
|
|
$ |
1,496,000 |
|
Professional fees |
|
|
492,000 |
|
|
|
414,000 |
|
Taxes |
|
|
641,000 |
|
|
|
768,000 |
|
Other |
|
|
331,000 |
|
|
|
446,000 |
|
|
|
|
|
|
|
|
Total accrued expenses |
|
$ |
2,282,000 |
|
|
$ |
3,124,000 |
|
|
|
|
|
|
|
|
F-14
11. Fair Value Measurements
Financial Accounting Standards Board (FASB) guidance regarding fair value measurement
establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active
markets for identical assets or liabilities; Level 2, defined as inputs other than quoted prices
for similar assets and liabilities in active markets that are either directly or indirectly
observable; and Level 3, defined as unobservable inputs for which little or no market data exists,
therefore requiring an entity to develop its own assumptions.
For certain of the Companys financial instruments, including cash and cash equivalents, trade
receivables, and accounts payable, the fair values approximate carrying values due to the
short-term maturities of these instruments. The carrying values of other current assets and accrued
expenses are also not recorded at fair value, but approximate fair values primarily due to their
short-term nature.
12. Notes Payable
License Subscription Note Payable
We entered into a financing agreement with CIT Financial in May 2009 to fund the purchase of
computer software licenses. The note was for $390,000 and was non-interest bearing (imputed
interest at 8.6%) and is payable in 36 equal monthly installments of $12,000 per month with the
final payment scheduled for April 2012. The remaining note payable at December 31, 2010, was
$186,000; of which $137,000 was current and $49,000 was non-current. We did not have any debt
activity during 2008.
13. April 2006 Private Placement of Common Stock
On April 5, 2006, we sold, in a private placement transaction, an aggregate of 9,930,000 units
consisting of (i) one share of common stock of the Company, par value $0.01 per share and (ii) a
related warrant to purchase 0.60 of one share of common stock. The units were sold for a purchase
price of $1.19 per unit. Total proceeds from the transaction were $11,817,000 (net proceeds to us
were $10,964,000 after $853,000 of cash transaction costs). The net proceeds were used for working
capital and general corporate purposes, including funding our business plan.
The transaction resulted in our issuing 9,930,000 shares of common stock and 5,958,000
warrants to purchase our common stock. The warrants have a 66-month term and any unexercised
options will expire October 2011. The exercise price of the warrants is $1.54 per share. The
warrants contain anti-dilution protection for stock splits and similar events, but do not contain
any price-based anti-dilution adjustments. If any of the 5,958,000 warrants issued to investors in
this transaction are exercised at any time, the underwriters will receive additional transaction
fees totaling 1% of the proceeds received from the warrant exercise. During 2010, 1,915,000
warrants were exercised, generating cash proceeds of approximately $2,949,000 and fees payable to
the underwriters of approximately $29,000. During 2009, 65,190 warrants were exercised, generating
cash proceeds of approximately $100,000 and fees payable to the underwriters of approximately
$1,000. There were no warrants exercised in 2008.
The potential future payments to the transaction underwriters were considered a contingent
liability and recorded as an accrued expense. This contingent liability is revalued each quarter
with the change in valuation recorded as a gain or loss in the statement of operations. The total
liability recorded is $36,000 and $60,000 at December 31, 2010 and 2009, respectively, and is
included in accrued expenses.
The stock purchase agreement required us to register the common stock issued and the common
stock issuable upon exercise of the warrants. We filed a registration statement with the Securities
and Exchange Commission (SEC) and the SEC declared the registration statement effective in May
2006. The registration statement remained effective as of March 10, 2011.
F-15
14. Equity Financing Arrangements and Related Warrants
Warrants Summary
Below is a summary of warrant activity during 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
|
Exercise |
|
|
Warrant |
|
Warrant Grants: |
|
Outstanding |
|
|
Issued |
|
|
Expired |
|
|
Exercised |
|
|
Outstanding |
|
|
Price |
|
|
Expiration |
|
2006 private placement of common stock
(See Note 13) |
|
|
4,347,810 |
|
|
|
|
|
|
|
|
|
|
|
(1,915,000 |
) |
|
|
2,432,810 |
|
|
$ |
1.54 |
|
|
Oct 2011 |
2005 private placement of common stock |
|
|
3,231,974 |
|
|
|
|
|
|
|
(3,231,974 |
) |
|
|
|
|
|
|
|
|
|
|
3.04 |
|
|
Aug 2010 |
2005 private placement broker warrants |
|
|
108,964 |
|
|
|
|
|
|
|
(108,964 |
) |
|
|
|
|
|
|
|
|
|
|
3.04 |
|
|
Aug 2010 |
2005 private placement agent warrants |
|
|
178,111 |
|
|
|
|
|
|
|
(178,111 |
) |
|
|
|
|
|
|
|
|
|
|
3.04 |
|
|
Aug 2010 |
2002 private placement of equity securities |
|
|
916,667 |
|
|
|
|
|
|
|
(916,667 |
) |
|
|
|
|
|
|
|
|
|
|
57.60 |
|
|
May 2010 |
Promissory note payable |
|
|
145,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
145,853 |
|
|
|
4.48 |
|
|
Jan 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
8,929,379 |
|
|
|
|
|
|
|
(4,435,716 |
) |
|
|
(1,915,000 |
) |
|
|
2,578,663 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The equity financing arrangements in which the warrants were included are explained
below.
2006 Private Placement of Common Stock and Warrants
On April 2006 we sold, in a private placement transaction, an aggregate of 9,930,000 units
consisting of (i) one share of our common stock, par value $0.01 per share and (ii) a related
warrant to purchase 0.60 of one share of common stock. The units were sold for a purchase price of
$1.19 per unit. Total proceeds from the transaction were $11,817,000. See Note 13.
2005 Private Placement of Common Stock and Warrants
In August 2005 we entered into a Securities Purchase Agreement (the Purchase Agreement) with
certain purchasers (collectively, the Purchasers) to issue and sell an aggregate of 10,503,862
units consisting of (i) one share of our common stock, par value $0.01 per share (the Common
Stock), and (ii) a related warrant to purchase one-third of one share of Common Stock. The units
were sold for a purchase price of $2.50 per unit, except in the case of units purchased by our
officers and directors, which were sold at a purchase price of $2.99 per unit. Total proceeds from
the private placement were $26,288,000 before transaction costs of $2,087,000. We used the net
proceeds for working capital and general corporate purposes.
Our officers and directors purchased 56,862 shares for $170,000 of the $26,288,000 total
proceeds and received 18,764 warrants.
All of the 3,231,974 warrants originally included in the private placement had a five-year
term and were exercisable at any time following the six-month anniversary of the closing of the
Purchase Agreement. The exercise price of the warrants was $3.04 per share. The warrants contained
anti-dilution protection for stock splits and similar events, but did not contain any price-based
anti-dilution adjustments. No warrants were exercised for the twelve months ended December 31,
2010, 2009 or 2008. The remainder of the warrants issued pursuant to this financing expired in
August 2010.
As part of their compensation for advising us during the transaction, the placement agent for
the private placement received 178,111 five-year warrants at a purchase price of $3.04 per share,
identical to those issued to the Purchasers. Because the Investors from a 2004 Private Placement of
Convertible Notes Payable also participated in the private placement under their right of first
refusal, the debt broker was issued 108,964 five-year warrants at a purchase price of $3.04 per
share, identical to those issued to the Purchasers. None of these warrants were exercised and all
were expired in August 2010.
The total warrants of 3,753,349 issued in connection with the 2005 private placement were
valued at $7,938,000 using the BSOPM and were assigned a value of $5,202,000 based on their
relative fair value with the common shares issued in the private placement, which was included in
additional paid-in-capital.
2002 Private Placement of Equity Securities
In 2000, through a private placement, we received cash of $44,000,000 in exchange of 916,667
shares of common stock, ten-year warrants to purchase 916,667 shares of our common stock at $57.60
per share and four-year
F-16
warrants to purchase 1,222,223 shares of our common stock at $12.00 per share. In May 2010,
916,667 of the ten-year warrants were expired and all four-year warrants had been exercised.
15. Earnings Per Share and Potential Dilution
Basic earnings per share are computed using the weighted average number of common shares
outstanding for the period. The dilutive effect of potential common shares outstanding is included
in diluted earnings per share. The computations for basic and diluted earnings per share for the
years ended December 31, 2010, 2009 and 2008, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Basic weighted average shares |
|
|
64,401,384 |
|
|
|
63,422,088 |
|
|
|
62,981,958 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Employee and director stock options |
|
|
913,670 |
|
|
|
211,185 |
|
|
|
771,042 |
|
Warrants |
|
|
1,426,627 |
|
|
|
417,478 |
|
|
|
2,103,382 |
|
|
|
|
|
|
|
|
|
|
|
Potential dilutive common shares |
|
|
66,741,681 |
|
|
|
64,050,751 |
|
|
|
65,856,382 |
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2010, 2009 and 2008, weighted average shares related to
certain stock options of 6,648,077, 8,518,982 and 6,971,635 respectively, were excluded from the
calculation of diluted earnings per share because the stock options were anti-dilutive.
Anti-dilutive warrants of 2,134,544, 7,677,196, and 5,008,501 for the years ended December 31,
2010, 2009 and 2008, respectively, were also excluded from the calculation.
16. Significant Customers
In 2010, 2009 and 2008, no single customer accounted for 10% or more of our revenues.
17. Commitments and Contingencies
Leases and Debt
We
lease office facilities under non-cancelable operating lease
agreements. Our continuing operations includes rent expense for
these operating leases of $1,288,000, $1,334,000, and $1,247,000 in 2010, 2009, and 2008,
respectively.
A summary of our fixed contractual obligations and commitments at December 31, 2010, is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2014 |
|
|
2015 |
|
|
Thereafter |
|
|
Total |
|
Operating leases |
|
$ |
1,290,000 |
|
|
$ |
958,000 |
|
|
$ |
887,000 |
|
|
$ |
665,000 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,800,000 |
|
License subscription note payable |
|
|
137,000 |
|
|
|
49,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
186,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash obligations |
|
|
1,427,000 |
|
|
|
1,007,000 |
|
|
|
887,000 |
|
|
|
665,000 |
|
|
|
|
|
|
|
|
|
|
|
3,986,000 |
|
Interest on obligations |
|
|
11,000 |
|
|
|
1,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,438,000 |
|
|
$ |
1,008,000 |
|
|
$ |
887,000 |
|
|
$ |
665,000 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,998,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims and Proceedings
We are subject to legal proceedings, claims, and litigation arising in the ordinary course of
our business. While the outcome of these matters is currently not determinable, we do not expect
that the ultimate costs to resolve these matters will have a material adverse effect on our
consolidated financial statements.
18. Income Taxes
Components of the income taxes are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S |
|
$ |
(99,000 |
) |
|
$ |
(95,000 |
) |
|
$ |
(111,000 |
) |
State |
|
|
33,000 |
|
|
|
(20,000 |
) |
|
|
22,000 |
|
Foreign |
|
|
126,000 |
|
|
|
179,000 |
|
|
|
139,000 |
|
Deferred |
|
|
|
|
|
|
|
|
|
|
|
|
F-17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Federal |
|
|
(35,300,000 |
) |
|
|
|
|
|
|
|
|
State |
|
|
|
|
|
|
|
|
|
|
(48,000 |
) |
Foreign |
|
|
9,000 |
|
|
|
3,000 |
|
|
|
40,000 |
|
|
|
|
|
|
|
|
|
|
|
Income tax (benefit) expense |
|
|
(35,231,000 |
) |
|
|
67,000 |
|
|
|
42,000 |
|
Discontinued operations |
|
|
269,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
(35,500,000 |
) |
|
$ |
67,000 |
|
|
$ |
42,000 |
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the expected U.S. tax (benefit) expense to income taxes is as follows:
|
|
|
|
2010 |
|
|
2009 |
|
|
2008 |
|
Expected tax
expense (benefit) at U.S. statutory rate |
|
$ |
1,988,000 |
|
|
$ |
(1,527,000 |
) |
|
$ |
(1,902,000 |
) |
Decrease in valuations allowance- Operations |
|
|
(2,574,000 |
) |
|
|
|
|
|
|
|
|
Decrease in valuations allowance- Other |
|
|
(35,300,000 |
) |
|
|
|
|
|
|
|
|
Unbenefited U.S. losses, net |
|
|
|
|
|
|
1,546,000 |
|
|
|
1,945,000 |
|
Nondeductible expense and nontaxable income |
|
|
141,000 |
|
|
|
(19,000 |
) |
|
|
(43,000 |
) |
Refundable U.S. research credits |
|
|
(50,000 |
) |
|
|
(95,000 |
) |
|
|
(111,000 |
) |
State income taxes |
|
|
(80,000 |
) |
|
|
(20,000 |
) |
|
|
(26,000 |
) |
Foreign income taxes |
|
|
134,000 |
|
|
|
182,000 |
|
|
|
179,000 |
|
Other |
|
|
510,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax (benefit) expense |
|
|
(35,231,000 |
) |
|
|
67,000 |
|
|
|
42,000 |
|
Discontinued operations |
|
|
269,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
(35,500,000 |
) |
|
$ |
67,000 |
|
|
$ |
42,000 |
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes reflect the net tax effects of temporary differences between the
carrying amounts of assets and liabilities for financial reporting purposes and the amounts used
for income tax purposes. Components of our deferred income taxes as of December 31, 2010 and 2009
are as follows:
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
2009 |
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
Nondeductible reserves |
|
$ |
176,000 |
|
|
$ |
193,000 |
|
U.S. net operating loss carryforwards |
|
|
97,308,000 |
|
|
|
98,206,000 |
|
State net operating loss carryforwards |
|
|
128,000 |
|
|
|
144,000 |
|
Tax credit carryforwards |
|
|
5,343,000 |
|
|
|
5,494,000 |
|
Stock-based compensation |
|
|
4,049,000 |
|
|
|
4,364,000 |
|
Intangible assets |
|
|
2,335,000 |
|
|
|
2,848,000 |
|
Depreciable assets |
|
|
1,184,000 |
|
|
|
1,438,000 |
|
Unrecognized gain on derivatives |
|
|
13,000 |
|
|
|
21,000 |
|
Other assets |
|
|
527,000 |
|
|
|
571,000 |
|
|
|
|
|
|
|
|
Total deferred tax assets |
|
|
111,063,000 |
|
|
|
113,279,000 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
Prepaid expenses |
|
|
(351,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets |
|
|
110,712,000 |
|
|
|
113,279,000 |
|
|
|
|
|
|
|
|
Less valuation allowance |
|
|
(75,352,000 |
) |
|
|
(113,210,000 |
) |
|
|
|
|
|
|
|
Net deferred income taxes |
|
$ |
35,360,000 |
|
|
$ |
69,000 |
|
|
|
|
|
|
|
|
The Company has partially reserved its U.S. net deferred tax assets in 2010 and 2009 due to
the uncertainty of future taxable income. The Company has U.S. net operating loss carryforwards of
approximately $286,201,000 which begin to expire in 2019. The Companys state net operating loss
carryforwards, approximately $71,678,000 of which was converted to a tax credit totaling
$3,226,000, will expire in 2027. At December 31, 2010, the remaining balance of these tax credits
was $3,008,000. The Company also has tax credit carryforwards of approximately $3,152,000
consisting of business tax credits which began to expire in 2010 and alternative minimum tax
credits which do not expire.
In 2010, the Company achieved positive earnings and successfully discontinued operations of
its e-Prescribing segment. Based on the weight of available objective evidence, including the
Companys history of positive earnings from continuing operations and successful exit from
e-Prescribing, management believes that it is more likely than not that a portion of the deferred
tax asset will be realized. Accordingly, the Company reduced its valuation
F-18
allowance by $35,300,000 in 2010. The benefit from the reduction was recorded as a tax
benefit in accordance with accounting standards for income taxes.
We have determined that utilization of existing net operating losses against future taxable
income is not limited by Section 382 of the Internal Revenue Code. Future ownership changes,
however, may limit the companys ability to fully utilize its existing net operating loss
carryforwards against any future taxable income.
The Company previously recorded a $327,000 tax contingency liability related to tax year 2004,
and that amount and the specifics therein have remained unchanged except for currency translation
adjustments. As of December 31, 2010, the gross amount of our unrecognized tax benefits, inclusive
of the $327,000 tax liability and $50,000 in other uncertain positions in 2008, was approximately
$461,000. Included in this balance are tax positions which, if recognized, would impact our
effective tax rate.
A reconciliation of the changes in the gross balance of unrecognized tax benefits amounts
during 2010 follows:
|
|
|
|
|
|
|
Unrecognized |
|
|
|
Tax Benefits |
|
Balance at December 31, 2008 |
|
$ |
377,000 |
|
Change in beginning balance due to currency fluctuation |
|
|
63,000 |
|
Additions based on tax positions related to current year |
|
|
|
|
Decreases based on tax positions related to current year |
|
|
|
|
Additions based on tax positions related to prior years |
|
|
|
|
Decreases based on tax positions related to prior years |
|
|
|
|
Additions based on tax positions related to settlements |
|
|
|
|
Decreases related to lapse of statute of limitations |
|
|
|
|
|
|
|
|
Balance at December 31, 2009 |
|
|
440,000 |
|
Change in beginning balance due to currency fluctuation |
|
|
21,000 |
|
Additions based on tax positions related to current year |
|
|
|
|
Decreases based on tax positions related to current year |
|
|
|
|
Additions based on tax positions related to prior years |
|
|
|
|
Decreases based on tax positions related to prior years |
|
|
|
|
Additions based on tax positions related to settlements |
|
|
|
|
Decreases related to lapse of statute of limitations |
|
|
|
|
|
|
|
|
Balance at December 31, 2010 |
|
$ |
461,000 |
|
|
|
|
|
We record accrued interest and penalties related to unrecognized tax benefits in selling,
general and administrative expense. There was an insignificant amount of interest expense and
penalties accrued or recognized related to unrecognized tax benefits for the years ended December
31, 2010 and 2009.
The Company or one of our subsidiaries files income tax returns in the U.S. federal
jurisdiction and various states and in the Canadian federal and provincial jurisdictions. We have
not taken a tax position that, if challenged, would have a material effect on the financial
statements or the effective tax rate for the twelve-months ended December 31, 2010, or during the
prior three years. We have determined it is not reasonably possible for the amounts of unrecognized
tax benefits to significantly increase or decrease within the next twelve months. We are currently
subject to a three-year statute of limitations by major tax jurisdictions.
19. Employee Benefit Plan
401(k) Plan We have a retirement savings plan structured under Section 401(k) of the
Internal Revenue Code covering substantially all of our U.S. employees. Under the plan,
contributions are voluntarily made by employees, and we may provide contributions based on the
employees contributions. Our operating income in 2010 includes
$210,000 for net contributions from continuing operations to
this plan.
The decline in our 2010 contribution compared to 2009 is
the result of headcount reductions.
Our operating losses include $245,000, and $243,000, in 2009 and 2008, respectively,
for net contributions from continuing operations to this plan.
20. Quarterly Results of Operations (Unaudited)
The following is a summary of the quarterly results of operations for the years ended December 31,
2010 and 2009:
F-19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
|
|
March 31 |
|
|
June 30 |
|
|
September 30 |
|
|
December 31 |
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
7,479,000 |
|
|
$ |
8,194,000 |
|
|
$ |
8,548,000 |
|
|
$ |
8,845,000 |
|
Gross margin |
|
|
5,977,000 |
|
|
|
6,624,000 |
|
|
|
6,886,000 |
|
|
|
7,111,000 |
|
Income from continuing operations |
|
|
524,000 |
|
|
|
1,379,000 |
|
|
|
1,671,000 |
|
|
|
37,146,000 |
|
Basic income from continuing
operations per common share* |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.03 |
|
|
|
0.57 |
|
Diluted income from continuing
operations per common share* |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.03 |
|
|
|
0.54 |
|
Income from discontinued operations |
|
|
188,000 |
|
|
|
122,000 |
|
|
|
97,000 |
|
|
|
86,000 |
|
Basic income from discontinued
operations per common share* |
|
|
0.00 |
|
|
|
0.00 |
|
|
|
0.00 |
|
|
|
0.00 |
|
Diluted income from discontinued
per common share* |
|
|
0.00 |
|
|
|
0.00 |
|
|
|
0.00 |
|
|
|
0.00 |
|
Net income |
|
|
712,000 |
|
|
|
1,501,000 |
|
|
|
1,768,000 |
|
|
|
37,232,000 |
|
Basic net income per common share* |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.03 |
|
|
|
0.57 |
|
Diluted net income per common share* |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.03 |
|
|
|
0.54 |
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
6,242,000 |
|
|
$ |
6,379,000 |
|
|
$ |
6,685,000 |
|
|
$ |
7,101,000 |
|
Gross margin |
|
|
5,229,000 |
|
|
|
5,291,000 |
|
|
|
5,506,000 |
|
|
|
5,805,000 |
|
Income from continuing operations |
|
|
747,000 |
|
|
|
112,000 |
|
|
|
723,000 |
|
|
|
829,000 |
|
Basic income from continuing
operations per common share* |
|
|
0.01 |
|
|
|
0.00 |
|
|
|
0.01 |
|
|
|
0.01 |
|
Diluted income from continuing
operations per common share* |
|
|
0.01 |
|
|
|
0.00 |
|
|
|
0.01 |
|
|
|
0.01 |
|
Loss from discontinued operations |
|
|
(2,289,000 |
) |
|
|
(2,037,000 |
) |
|
|
(1,380,000 |
) |
|
|
(1,140,000 |
) |
Basic loss from discontinued
operations per common share* |
|
|
(0.03 |
) |
|
|
(0.03 |
) |
|
|
(0.02 |
) |
|
|
(0.01 |
) |
Diluted loss from discontinued
operations per common share* |
|
|
(0.03 |
) |
|
|
(0.03 |
) |
|
|
(0.02 |
) |
|
|
(0.01 |
) |
Net loss |
|
|
(1,542,000 |
) |
|
|
(1,925,000 |
) |
|
|
(657,000 |
) |
|
|
(311,000 |
) |
Basic net loss per common share* |
|
|
(0.02 |
) |
|
|
(0.03 |
) |
|
|
(0.01 |
) |
|
|
(0.00 |
) |
Diluted net loss per common share* |
|
|
(0.02 |
) |
|
|
(0.03 |
) |
|
|
(0.01 |
) |
|
|
(0.00 |
) |
|
|
|
* |
|
Net loss per share is calculated independently for each quarter. The sum of Net loss per share
for each quarter does not equal the total Net loss per share for the year due to rounding
differences. |
21. Subsequent Events
On March 7, 2011, the Company announced that its board of directors approved a share
repurchase program that enables the Company to purchase up to $15 million of its shares of common
stock from time to time in the open market. The amount and timing of specific repurchases are
subject to market conditions, applicable legal requirements and other factors. The share purchases
will be funded from existing cash resources and
may be suspended or discontinued at any time, however, the share repurchase program will expire on
September 30, 2011.
F-20